[
    {
        "text": "after # weeks of ddrug0 treatment , all ddrug1 / vehicle-treated animals displayed parkinsonian symptoms , whereas none of the ddrug2 / ddrug3 - treated monkeys were significantly affected .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "these behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data , and with post-mortem stereological counts of midbrain dopaminergic neurons , as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity , which were all significantly higher in ddrug0 / ddrug1 - treated animals than in ddrug2 / vehicle-treated monkeys .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the ddrug0 treatment also had a significant effect on the ddrug1 - induced loss of norepinephrine neurons in the locus coeruleus and adjoining a5 and a7 noradrenaline cell groups .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in ddrug0 / vehicle-treated animals , almost 40 % loss of tyrosine hydroxylase-positive norepinephrine neurons was found in locus coeruleus/a5/a7 noradrenaline cell groups , whereas the extent of neuronal loss was lower than 15 % of control values in ddrug1 / ddrug2 - treated monkeys .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "our data demonstrate that chronic treatment with the metabotropic glutamate receptor # antagonist , ddrug0 , significantly reduces ddrug1 toxicity towards dopaminergic and noradrenergic cell groups in non-human primates .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in the presence of ddrug0 , there was # - and # - fold increase in c { max } and auc of ddrug1 , respectively .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with ddrug2 and ddrug3 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with ddrug2 and ddrug3 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with ddrug2 and ddrug3 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with ddrug2 and ddrug3 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with ddrug2 and ddrug3 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with ddrug2 and ddrug3 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with ddrug2 and ddrug3 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with ddrug2 and ddrug3 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "exposure to oral ddrug0 is unaffected by ddrug1 but greatly increased by ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity { auc { 0 - } } of oral ddrug1 by # - fold , whereas ddrug2 treatment did not increase the exposure to ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the findings suggest that the dosage of ddrug0 should be reduced in patients receiving ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "we also found that bcl-2 was overexpressed in ddrug0 insensitive cells , and cotreatment with ddrug1 and ddrug2 , a bcl2 family inhibitor , synergistically inhibited growth and induced apoptosis of ddrug3 insensitive mm cells .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "in addition , ddrug0 insensitivity might be associated with overexpression of bcl-2 , and the combination of ddrug1 and ddrug2 could synergistically induced apoptosis .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 failure in an hiv-positive woman on ddrug1 therapy resulting in two ectopic pregnancies .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "we present an interesting case of an hiv-positive woman on ddrug0 therapy having tubal pregnancies on two separate occasions with ddrug1 in place .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of ddrug1 { or = # -lsb- 95 % ci , ## -rsb- } , ddrug2 { or = # -lsb- 95 % ci , ## -rsb- } , ddrug3 { or = # -lsb- 95 % ci , ## -rsb- } , ddrug4 { or = # -lsb- 95 % ci , ## -rsb- } .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of ddrug1 { or = # -lsb- 95 % ci , ## -rsb- } , ddrug2 { or = # -lsb- 95 % ci , ## -rsb- } , ddrug3 { or = # -lsb- 95 % ci , ## -rsb- } , ddrug4 { or = # -lsb- 95 % ci , ## -rsb- } .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of ddrug1 { or = # -lsb- 95 % ci , ## -rsb- } , ddrug2 { or = # -lsb- 95 % ci , ## -rsb- } , ddrug3 { or = # -lsb- 95 % ci , ## -rsb- } , ddrug4 { or = # -lsb- 95 % ci , ## -rsb- } .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of ddrug1 { or = # -lsb- 95 % ci , ## -rsb- } , ddrug2 { or = # -lsb- 95 % ci , ## -rsb- } , ddrug3 { or = # -lsb- 95 % ci , ## -rsb- } , ddrug4 { or = # -lsb- 95 % ci , ## -rsb- } .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "also ddrug0 , which is not believed to interact with ddrug1 , increased the risk of gi bleeding { or = # -lsb- 95 % ci , ## -rsb- } .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 users who initiated ddrug1 , ddrug2 , ddrug3 , ddrug4 , or ddrug5 had an increased risk of hospitalization for gastrointestinal bleeding .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 users who initiated ddrug1 , ddrug2 , ddrug3 , ddrug4 , or ddrug5 had an increased risk of hospitalization for gastrointestinal bleeding .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 users who initiated ddrug1 , ddrug2 , ddrug3 , ddrug4 , or ddrug5 had an increased risk of hospitalization for gastrointestinal bleeding .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 users who initiated ddrug1 , ddrug2 , ddrug3 , ddrug4 , or ddrug5 had an increased risk of hospitalization for gastrointestinal bleeding .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 users who initiated ddrug1 , ddrug2 , ddrug3 , ddrug4 , or ddrug5 had an increased risk of hospitalization for gastrointestinal bleeding .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 decreased the toxicity of ddrug1 , increased exposure to parent compound , and decreased metabolite levels in a dose-dependent manner .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 had no effect , while ddrug2 appeared to augment ddrug3 toxicity .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 - mediated retinal transduction is improved by co-injection of ddrug1 or ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 - mediated retinal transduction is improved by co-injection of ddrug1 or ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "based on this experience , we suggest that low-dose ddrug0 added to ddrug1 may be associated with prevention of ea in children with a history of ea with ddrug2 tiva .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 reduce the plasma concentration of ddrug2 by about 50 % .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 reduce the plasma concentration of ddrug2 by about 50 % .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with ddrug0 for breast cancer , especially ddrug1 such as ddrug2 and ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with ddrug0 for breast cancer , especially ddrug1 such as ddrug2 and ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with ddrug0 for breast cancer , especially ddrug1 such as ddrug2 and ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "if in certain cases , an ddrug0 is considered necessary , it may be advisable to replace ddrug1 with ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in female rats , neonatal ddrug0 treatment enhanced ddrug1 locomotor sensitization compared with ddrug2 - free controls sensitized to ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "systemic and apparent oral ddrug0 clearance were 24 % { 269 # vs , # # ml/min , p = # } and 31 % { 479 # vs , # # ml/min , p = # } , respectively , lower in ddrug1 - treated patients { n = 20 } than in matched ddrug2 - treated patients { n = 20 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "reduction of pth by ddrug0 is associated with a decrease in ddrug1 requirement .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "interaction of ddrug0 with different ddrug1 is antagonistic in breast but not in other cancer cells .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "we found antagonism between ddrug0 and the four drugs in the breast_cancer cells mcf7 following all incubation schedules and between ddrug1 and ddrug2 in all cell_line except for two combinations in hct116 cells .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "concomitant use of ddrug0 and ddrug1 was found to decrease the exposure { auc } to clopidogrel 's active metabolite by 50 % and to sharply increase platelet reactivity , as a result of inhibition by ddrug2 of cyp2c19 , a cytochrome cyp2b6 { cyp } enzyme .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 has a much weaker effect on ddrug1 's pharmacokinetics and on platelet reactivity during concomitant use .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "regulatory agencies state that the combination of ddrug0 and the cyp2c19 inhibitors ddrug1 and ddrug2 should be avoided .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "regulatory agencies state that the combination of ddrug0 and the cyp2c19 inhibitors ddrug1 and ddrug2 should be avoided .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "the combination of ddrug0 and ddrug1 can be synergistic against mrsa .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the authors report the case of an infant with confirmed congenital hypothyroidism on ddrug0 who experienced a possible drug interaction with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 is the only known component in the diet that may affect absorption of both ddrug1 and ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 is the only known component in the diet that may affect absorption of both ddrug1 and ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "however , the evidence for a ddrug0 effect on ddrug1 absorption mainly comes from studies that did not isolate the effect of ddrug2 from that of other dietary components , because it was detected in single-meal studies .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 doses # mg diminished ddrug1 absorption by an average of # % .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "a ddrug0 dose of # mg diminished absorption of # mg ddrug1 by # % .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in conclusion , we demonstrated an isolated effect of ddrug0 { as chloride } on absorption of # mg of iron provided as ddrug1 { as sulfate } and ddrug2 { as crbc } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in conclusion , we demonstrated an isolated effect of ddrug0 { as chloride } on absorption of # mg of iron provided as ddrug1 { as sulfate } and ddrug2 { as crbc } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "synergistic interaction between ddrug0 and ddrug1 is sequence dependent in human non-small lung_cancer with egfr tkis-resistant mutation .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "although single or concurrent use of ddrug0 and ddrug1 has some anti-proliferative effects , the sequential administrations of both drugs remarkably enhanced anti-tumor activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "when cells were exposed to ddrug0 followed by ddrug1 , synergism was observed .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the molecular basis of this synergism is that the signaling pathways that were initially activated by ddrug0 exposure were efficiently suppressed by the subsequent exposure to ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 as a single agent exhibits anti-proliferative effects in vitro in non-small_cell_lung_cancer cell lines with egfr t790m and k-ras mutations but the sequential administration of ddrug1 followed by ddrug2 is superior to ddrug3 followed by ddrug4 and concurrent administration .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "distinct and statistically significant synergism was observed between ddrug0 and ddrug1 by disc diffusion tests when compared with their individual effects .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "synergism was also noted when ddrug0 was combined with ddrug1 and ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "synergism was also noted when ddrug0 was combined with ddrug1 and ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "{ ii } ddrug0 elicits a significant protective effect on deb induced toxicity , which was potentiated by ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "acute administration of ddrug0 or ddrug1 failed to influence locomotion in mice , while their combination normalized motor activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the role of p27 { kip1 } in ddrug0 - enhanced ddrug1 cytotoxicity in human ovarian_cancer cells .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "hey cells treated with ddrug0 plus ddrug1 formed fewer colonies than did cells treated with either agent alone .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "treatment of hey xenograft-bearing mice with ddrug0 plus ddrug1 inhibited tumor growth more than treatment with either agent alone { average tumor volume per mouse , ddrug2 + ddrug3 vs ddrug4 : # vs , # cm3 , difference = # cm3 , 95 % confidence interval -lsb- ci -rsb- = # to # cm3 , p = # } ;",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "studies with forced expression and sirna knockdown of bcl-2 and cdk1 suggest that ddrug0 - mediated induction of p27 { kip1 } enhanced ddrug1 - induced apoptosis by negatively regulating bcl2 and cdk1 expression .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "inhibition of src family and abl kinases with either sirnas or ddrug0 enhances ddrug1 sensitivity of ovarian_cancer cells through p27 { kip1 } - mediated suppression of bcl-2 and cdk1 expression .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the preclinical combination of ddrug0 with the mtor_inhibitor ddrug1 has displayed synergy in vitro and represents a novel combination in mm .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in experiment 2 , the same regimen of ddrug0 was administered to chickens inoculated with ddrug1 , and an enhanced serum antibody response to ai vaccination was also observed .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 show additive effects in vitro but not in vivo in human a-375 melanoma cells .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 enhances ddrug1 - mediated antibody-dependent cellular cytotoxicity by up-regulation of cell surface erbb2 expression .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "although it was previously reported that ddrug0 combined with ddrug1 improved the progression-free survival rate compared with ddrug2 alone for patients with ddrug3 - refractory her2-positive metastatic breast cancer , the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in an in vitro assay , ddrug0 induced erbb2 expression at the cell surface of her2-positive breast cancer cell lines , leading to the enhancement of ddrug1 - mediated adcc .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "furthermore , we present a case report in which a second ddrug0 treatment following ddrug1 resulted in the marked shrinkage of multiple metastatic tumors in her2-positive breast cancer .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 induced apoptosis , and furthermore , the combination of ddrug1 plus ddrug2 enhanced cytotoxicity in a t-all cell line .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 enhances the antinociceptive effect of ddrug1 in mice .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in the hot plate test in mice , co-administration of # g/kg ddrug0 with # mg/kg ddrug1 intraperitoneally not only enhanced , but also prolonged the duration of antinociception induced by ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "at the same time , the locomotor inhibitory effect of ddrug0 was counteracted by ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "we concluded that the combined administration of ddrug0 with ddrug1 may have beneficial effects in the treatment of pain without causing sedation , which limits the use of ddrug2 as an ddrug3 in humans .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the fda has approved ddrug0 { ddrug1 - astrazeneca } , an oral ddrug2 , for use with low-dose ddrug3 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome { acs } .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "the fda has approved ddrug0 { ddrug1 - astrazeneca } , an oral ddrug2 , for use with low-dose ddrug3 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome { acs } .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "in the present study ddrug0 { 10 mg/kg } significantly increased the dose-dependent antinociceptive activity of ddrug1 evaluated by both ddrug2 writhing and formalin test , when it was administered with ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 plasma concentration was also increased when it was administered with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the synergistic antinociception activity of ddrug0 when administered with ddrug1 can be attributed to increased plasma concentration of ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "from this study it can be concluded that ddrug0 can be used as a bioenhancer along with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 decreases the elimination of ddrug1 causing an increase in overall exposure , the addition of ddrug2 has no clinically significant effect on the pharmacokinetic properties of ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in a study of # hiv-infected patients receiving ddrug0 - maintenance therapy { 40 mg and # mg daily } with # mg of ddrug1 twice daily { twice the currently recommended dose } , oral ddrug2 clearance increased 22 % { 90 % ci 6 % to 42 % } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : concomitant ddrug1 administration decreased the mean auc of total ddrug2 approximately 55 % .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "the incremental ldl-c reduction due to adding ddrug0 to ddrug1 may be reduced by this interaction .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with ddrug1 is not recommended until use in patients is studied .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : in a pharmacokinetic study , concomitant ddrug1 administration increased total ddrug2 concentrations approximately # - fold .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : the total ddrug1 level increased 12-fold in one renal transplant patient receiving multiple medications , including ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "patients who take both ddrug0 and ddrug1 should be carefully monitored .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "triple_list": [
            [
                "ddrug13",
                "effect",
                "ddrug14"
            ]
        ]
    },
    {
        "text": "one fatality has been reported from hypoglycemia in association with combined ddrug0 and ddrug1 use .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 reduces the metabolism of ddrug1 , ddrug2 , and ddrug3 and increases the plasma concentration of these agents .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 reduces the metabolism of ddrug1 , ddrug2 , and ddrug3 and increases the plasma concentration of these agents .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 reduces the metabolism of ddrug1 , ddrug2 , and ddrug3 and increases the plasma concentration of these agents .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "when ddrug0 is used concomitantly with these or other ddrug1 , blood glucose concentrations should be carefully monitored and the dose of the ddrug2 should be adjusted as necessary .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : prothrombin time may be increased in patients receiving concomitant ddrug1 and ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "in post-marketing experience , as with other ddrug0 , bleeding events { bruising , epistaxis , gastrointestinal bleeding , hematuria , and melena } have been reported in association with increases in prothrombin time in patients receiving ddrug1 concurrently with ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "careful monitoring of prothrombin time in patients receiving ddrug0 and ddrug1 is recommended .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 increases the plasma concentrations of ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "careful monitoring of ddrug0 concentrations in patients receiving ddrug1 and ddrug2 is recommended .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 may significantly increase ddrug2 levels in renal transplant patients with or without renal impairment .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "careful monitoring of ddrug0 concentrations and serum creatinine is recommended in patients receiving ddrug1 and ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 enhances the metabolism of concurrently administered ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "depending on clinical circumstances , consideration should be given to increasing the dose of ddrug0 when it is administered with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 increases the serum concentrations of ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "careful monitoring of serum ddrug0 concentrations in patients receiving ddrug1 and ddrug2 is recommended .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the qtc interval in patients receiving ddrug1 in conjunction with ddrug2 , interaction studies have been performed .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "another study at a 400-mg and 800-mg daily dose of ddrug0 demonstrated that ddrug1 taken in doses of # mg per day or greater significantly increases plasma levels of ddrug2 when taken concomitantly .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "the combined use of ddrug0 at doses of # mg or greater with ddrug1 is contraindicated .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the coadministration of ddrug0 at doses lower than # mg/day with ddrug1 should be carefully monitored .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : there have been reports of cardiac events , including torsade de pointes in patients to whom ddrug1 and ddrug2 were coadministered .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "a controlled study found that concomitant ddrug0 # mg once daily and ddrug1 # mg four times a day yielded a significant increase in ddrug2 plasma levels and prolongation of qtc interval .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the combined use of ddrug0 with ddrug1 is contraindicated .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : the use of ddrug1 in patients concurrently taking ddrug2 or other drugs metabolized by the cytochrome cyp2b6 system may be associated with elevations in serum levels of these drugs .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : there have been reports of uveitis in patients to whom ddrug1 and ddrug2 were coadministered .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "patients receiving ddrug0 and ddrug1 concomitantly should be carefully monitored .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : there have been reports of nephrotoxicity in patients to whom ddrug1 and ddrug2 were coadministered .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "patients receiving ddrug0 and ddrug1 concomitantly should be carefully monitored .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : following oral administration of ddrug1 , ddrug2 resulted in substantial increases in ddrug3 concentrations and psychomotor effects .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "this effect on ddrug0 appears to be more pronounced following oral administration of ddrug1 than with ddrug2 administered intravenously .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "if ddrug0 , which are metabolized by the cytochrome cyp2b6 system , are concomitantly administered with ddrug1 , consideration should be given to decreasing the ddrug2 dosage , and the patients should be appropriately monitored .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 tablets coadministered with ddrug1 - and ddrug2 - containing oral ddrug3 produced an overall mean increase in ddrug4 and ddrug5 levels ;",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 tablets coadministered with ddrug1 - and ddrug2 - containing oral ddrug3 produced an overall mean increase in ddrug4 and ddrug5 levels ;",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "while there is evidence that ddrug0 can inhibit the metabolism of ddrug1 and ddrug2 , there is no evidence that ddrug3 is a net inducer of ddrug4 or ddrug5 metabolism .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "while there is evidence that ddrug0 can inhibit the metabolism of ddrug1 and ddrug2 , there is no evidence that ddrug3 is a net inducer of ddrug4 or ddrug5 metabolism .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "changes in ddrug0 and other diabetes drug therapies may be necessary during treatment with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may reduce the effects of ddrug1 { ddrug2 } .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may reduce the effects of ddrug1 { ddrug2 } .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "preliminary evidence suggests that ddrug0 inhibits ddrug1 metabolism and may result in an increase in plasma concentrations of ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "patients receiving ddrug0 and ddrug1 generally should not be treated with ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "patients receiving ddrug0 and ddrug1 generally should not be treated with ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "the action of ddrug0 may be potentiated by anesthesia , other ddrug1 and ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the action of ddrug0 may be potentiated by anesthesia , other ddrug1 and ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 administered concomitantly with ddrug1 may significantly decrease the serum concentrations of ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "a pharmacokinetic study demonstrated that coadministration of ddrug0 and ddrug1 results in a significant decrease in the pharmacokinetic parameters { ~ 36 % for cmax and ~ 28 % for auc } of ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "administration of a higher dose of ddrug0 should be considered when coadministering with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug12"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug13"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "triple_list": [
            [
                "ddrug10",
                "effect",
                "ddrug11"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "triple_list": [
            [
                "ddrug14",
                "effect",
                "ddrug15"
            ]
        ]
    },
    {
        "text": "ddrug0 reports suggest that ddrug1 may diminish the antihypertensive effect of ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "this interaction should be given consideration in patients taking ddrug0 concomitantly with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : concomitant administration of ddrug1 { 1000 mg tid } to healthy volunteers tended to increase the auc { 10 % } and cmax { 24 % } of ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "however , as with other ddrug0 , concomitant administration of ddrug1 and ddrug2 is not generally recommended because of the potential for increased adverse effects .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "however , as with other ddrug0 , concomitant administration of ddrug1 and ddrug2 is not generally recommended because of the potential for increased adverse effects .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "concomitant administration of low-dose ddrug0 with ddrug1 may result in an increased rate of gi ulceration or other complications , compared to use of ddrug2 alone .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : pretreatment for four days with ddrug1 significantly increased the clearance of ddrug2 by 50 % .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : clinical studies , as well as post-marketing observations , have shown that ddrug1 can reduce the natriuretic effect of ddrug2 and ddrug3 in some patients .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : clinical studies , as well as post-marketing observations , have shown that ddrug1 can reduce the natriuretic effect of ddrug2 and ddrug3 in some patients .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "nevertheless , during concomitant therapy with ddrug0 and ddrug1 , patients should be observed closely for signs of declining renal function , as well as to assure diuretic efficacy .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : in clinical trials , ddrug1 have produced an elevation of plasma ddrug2 levels and a reduction in renal ddrug3 clearance .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "in a study conducted in healthy subjects , mean pre-dose ddrug0 concentration and auc were increased by 21 % in subjects receiving ddrug1 doses ranging from # to # mg bid with ddrug2 # mg qd as compared to subjects receiving ddrug3 alone .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "patients on ddrug0 treatment should be closely monitored when ddrug1 is introduced or withdrawn .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : anticoagulant activity should be monitored , particularly in the first few days after initiating or changing ddrug1 therapy in patients receiving ddrug2 or similar agents , since these patients are at an increased risk of bleeding .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "caution should be used when administering ddrug0 with ddrug1 since patients on ddrug2 may experience changes in inr and an increased risk of bleeding complications when a new medication is introduced .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "drug interactions there are no known drug/drug interactions with oral ddrug0 vaccinations with ddrug1 are not recommended in immunocompromised individuals ddrug2 together with high-dose intravenous ddrug3 has caused deaths in children due to haemorrhagic enterocolitis .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "impaired renal function has been described in bone marrow transplant patients who were conditioned with high-dose intravenous ddrug0 and who subsequently received ddrug1 to prevent graft-versus-host disease",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug10"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug11"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug12"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug13"
            ]
        ]
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug14"
            ]
        ]
    },
    {
        "text": "ddrug0 antagonize the effects of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may affect gastrointestinal absorption of various drugs , such as slowly dissolving dosage forms of ddrug1 ;",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may antagonize the effects of drugs that alter gastrointestinal motility , such as ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "because ddrug0 may interfere with the absorption of ddrug1 , simultaneous use of these drugs should be avoided .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug10"
            ]
        ]
    },
    {
        "text": "some ddrug0 may interact with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 can interact with ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 can interact with ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 can interact with ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 can interact with ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 can interact with ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 competes with ddrug1 for active tubular secretion and thus inhibits the renal excretion of ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "therefore , the coadministration of ddrug0 with ddrug1 is not recommended .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "there is evidence that ddrug0 may reduce serum levels of ddrug1 to subtherapeutic levels { therapeutic range considered to be # to # g/ml total ddrug2 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 should be used with caution in digitalized patients , since the combination of ddrug1 and ddrug2 may cause ectopic arrhythmias .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 or ddrug1 may potentiate the action of ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 or ddrug1 may potentiate the action of ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may enhance the effects of ddrug1 , ddrug2 and other ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may enhance the effects of ddrug1 , ddrug2 and other ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may enhance the effects of ddrug1 , ddrug2 and other ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "caution is advised for patients receiving high-dose ddrug0 and ddrug1 concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high-dose ddrug2 and ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "caution is advised for patients receiving high-dose ddrug0 and ddrug1 concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high-dose ddrug2 and ddrug3 .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 { oral } : the activity of oral ddrug1 may be potentiated by anti-vitamin-k activity attributed to ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "dosages of concomitantly administered ddrug0 should be reduced by approximately half , because ddrug1 amplifies the therapeutic actions and side-effects of ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "dosages of concomitantly administered ddrug0 should be reduced by approximately half , because ddrug1 amplifies the therapeutic actions and side-effects of ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "additive sedative effects and confusional states may emerge if ddrug0 is given with ddrug1 or ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "additive sedative effects and confusional states may emerge if ddrug0 is given with ddrug1 or ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "exert particular caution in combining ddrug0 with other ddrug1 { ddrug2 and ddrug3 } : particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "exert particular caution in combining ddrug0 with other ddrug1 { ddrug2 and ddrug3 } : particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "exert particular caution in combining ddrug0 with other ddrug1 { ddrug2 and ddrug3 } : particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 and/or stimulantes of the ddrug1 / ddrug2 type may counteract the specific actions of ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 and/or stimulantes of the ddrug1 / ddrug2 type may counteract the specific actions of ddrug3 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 and/or stimulantes of the ddrug1 / ddrug2 type may counteract the specific actions of ddrug3 .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "since ddrug0 { ddrug1 } may interact with concurrently administered ddrug2 , periodic serum level determinations of these drugs may be necessary { eg ddrug3 may increase the plasma concentrations of ddrug4 and ddrug5 } .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "since ddrug0 { ddrug1 } may interact with concurrently administered ddrug2 , periodic serum level determinations of these drugs may be necessary { eg ddrug3 may increase the plasma concentrations of ddrug4 and ddrug5 } .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "since ddrug0 { ddrug1 } may interact with concurrently administered ddrug2 , periodic serum level determinations of these drugs may be necessary { eg ddrug3 may increase the plasma concentrations of ddrug4 and ddrug5 } .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "since ddrug0 { ddrug1 } may interact with concurrently administered ddrug2 , periodic serum level determinations of these drugs may be necessary { eg ddrug3 may increase the plasma concentrations of ddrug4 and ddrug5 } .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 may decrease arterial responsiveness to ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may increase the responsiveness of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 renal clearance is reduced by ddrug1 , increasing the risk of ddrug2 toxicity .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may add to or potentiate the action of other ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "when ddrug0 is used with other ddrug1 , potentiation of antihypertensive effect may occur .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "patients may require reduced doses of ddrug0 when on ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "when ddrug0 and ddrug1 are given concomitantly the patient should be carefully monitored for symptoms of ddrug2 toxicity .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "several studies demonstrate a decrease in the bioavailability of ddrug0 when it is ingested with ddrug1 or ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "several studies demonstrate a decrease in the bioavailability of ddrug0 when it is ingested with ddrug1 or ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "coadministration of ddrug0 with ddrug1 or ddrug2 is not recommended .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "coadministration of ddrug0 with ddrug1 or ddrug2 is not recommended .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "caution should be exercised when ddrug0 { ddrug1 } is used concurrently with other ddrug2 or ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "caution should be exercised when ddrug0 { ddrug1 } is used concurrently with other ddrug2 or ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "caution should be exercised when ddrug0 { ddrug1 } is used concurrently with other ddrug2 or ddrug3 .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may decrease the hypotensive effect of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "human pharmacologic studies have shown that ddrug0 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "human pharmacologic studies have shown that ddrug0 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "human pharmacologic studies have shown that ddrug0 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "human pharmacologic studies have shown that ddrug0 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "human pharmacologic studies have shown that ddrug0 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "human pharmacologic studies have shown that ddrug0 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "human pharmacologic studies have shown that ddrug0 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "human pharmacologic studies have shown that ddrug0 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "human pharmacologic studies have shown that ddrug0 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "human pharmacologic studies have shown that ddrug0 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug10"
            ]
        ]
    },
    {
        "text": "mutual inhibition of metabolism occurs with concurrent use of ddrug0 and ddrug1 ;",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "convulsions have been reported with concurrent use of ddrug0 and ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 , and ddrug2 may increase the clearance of ddrug3 and may require increased in ddrug4 dose to achieve the desired response .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 , and ddrug2 may increase the clearance of ddrug3 and may require increased in ddrug4 dose to achieve the desired response .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 , and ddrug2 may increase the clearance of ddrug3 and may require increased in ddrug4 dose to achieve the desired response .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 , and ddrug2 may increase the clearance of ddrug3 and may require increased in ddrug4 dose to achieve the desired response .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 , and ddrug2 may increase the clearance of ddrug3 and may require increased in ddrug4 dose to achieve the desired response .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 , and ddrug2 may increase the clearance of ddrug3 and may require increased in ddrug4 dose to achieve the desired response .",
        "triple_list": [
            [
                "ddrug2",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "drugs such as ddrug0 and ddrug1 may inhibit the metabolism of ddrug2 and thus decrease its clearance .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "drugs such as ddrug0 and ddrug1 may inhibit the metabolism of ddrug2 and thus decrease its clearance .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may increase the clearance of chronic high dose ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "this could lead to decreased ddrug0 serum levels or increase the risk of ddrug1 toxicity when ddrug2 is withdrawn .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 should be used cautiously in conjunction with ddrug1 in patients suffering from hypoprothrombinemia .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "there are reports of enhanced as well as diminished effects of ddrug0 when given concurrently with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug10"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug11"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug12"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug13"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug14"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug15"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug16"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug17"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug18"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug19"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug20"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug21"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug22"
            ]
        ]
    },
    {
        "text": "concurrent use of ddrug0 and other ddrug1 may increase the cns depressant effects of ddrug2 or these other medications .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "concurrent use of ddrug0 and other ddrug1 may increase the cns depressant effects of ddrug2 or these other medications .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may reverse the analgesic activity of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the effects of ddrug0 on gastrointestinal motility are antagonized by ddrug1 and ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the effects of ddrug0 on gastrointestinal motility are antagonized by ddrug1 and ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "additive sedative effects can occur when ddrug0 is given with ddrug1 , ddrug2 , ddrug3 , ddrug4 , or ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "additive sedative effects can occur when ddrug0 is given with ddrug1 , ddrug2 , ddrug3 , ddrug4 , or ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "additive sedative effects can occur when ddrug0 is given with ddrug1 , ddrug2 , ddrug3 , ddrug4 , or ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "additive sedative effects can occur when ddrug0 is given with ddrug1 , ddrug2 , ddrug3 , ddrug4 , or ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "additive sedative effects can occur when ddrug0 is given with ddrug1 , ddrug2 , ddrug3 , ddrug4 , or ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "the finding that ddrug0 releases catecholamines in patients with essential hypertension suggests that it should be used cautiously , if at all , in patients receiving ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "absorption of drugs from the stomach may be diminished { e , g , , ddrug0 } by ddrug1 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased { e , g , , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "absorption of drugs from the stomach may be diminished { e , g , , ddrug0 } by ddrug1 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased { e , g , , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 } .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "because the action of ddrug0 will influence the delivery of food to the intestines and thus the rate of absorption , ddrug1 dosage or timing of dosage may require adjustment .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 and probably other ddrug2 given concomitantly with ddrug3 can cause unusually large or prolonged losses of fluid and electrolytes .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 and probably other ddrug2 given concomitantly with ddrug3 can cause unusually large or prolonged losses of fluid and electrolytes .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "other ddrug0 : when ddrug1 tablets are used with other ddrug2 , care must be taken , especially during initial therapy .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 - induced hypokalemia can increase the sensitivity of the myocardium to ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 - induced hypokalemia may enhance neuromuscular blocking effects of ddrug2 { such as ddrug3 } the most serious effect would be respiratory_failure which could proceed to apnea .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 - induced hypokalemia may enhance neuromuscular blocking effects of ddrug2 { such as ddrug3 } the most serious effect would be respiratory_failure which could proceed to apnea .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 and other ddrug1 : may decrease the antihypertensive effects of ddrug2 tablets .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 and other ddrug1 : may decrease the antihypertensive effects of ddrug2 tablets .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 may decrease arterial responsiveness to ddrug2 , but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : efficacy may be decreased due to urinary alkalizing effect of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 , as well as other ddrug2 , may affect the hypoprothrombinemic response to ddrug3 ;",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "catecholamine-depleting drugs { e , g , , ddrug0 } may have an additive effect when given with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "oral ddrug0 has been reported to potentiate the anticoagulant effect of ddrug1 and ddrug2 , resulting in a prolongation of prothrombin time .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "oral ddrug0 has been reported to potentiate the anticoagulant effect of ddrug1 and ddrug2 , resulting in a prolongation of prothrombin time .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "the metabolism of ddrug0 is accelerated by ddrug1 ;",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 inhibits the glucuronidation of ddrug1 and could possibly potentiate ddrug2 toxicity .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 inhibits the glucuronidation of ddrug1 and could possibly potentiate ddrug2 toxicity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "caution should be observed in administering ddrug0 to patients receiving ddrug1 or ddrug2 because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "caution should be observed in administering ddrug0 to patients receiving ddrug1 or ddrug2 because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "concurrent use of ddrug0 with ddrug1 or other ddrug2 can increase their sedative effects .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "concurrent use of ddrug0 with ddrug1 or other ddrug2 can increase their sedative effects .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "in a formal , single-dose interaction study { n = # males } the clearance of ddrug0 was decreased by 38 % following the coadministration of ddrug1 , an inhibitor of cyp1a2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "when ddrug0 or other hepatic enzyme inducers such as ddrug1 and ddrug2 have been taken concurrently with ddrug3 , lowered ddrug4 plasma levels have been reported .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "when ddrug0 or other hepatic enzyme inducers such as ddrug1 and ddrug2 have been taken concurrently with ddrug3 , lowered ddrug4 plasma levels have been reported .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "when ddrug0 or other hepatic enzyme inducers such as ddrug1 and ddrug2 have been taken concurrently with ddrug3 , lowered ddrug4 plasma levels have been reported .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "concurrent administration of ddrug0 and ddrug1 has been reported to increase , decrease , or leave unchanged ddrug2 plasma levels ;",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 does not alter serum ddrug1 levels but ddrug2 , when used to treat gastrointestinal symptoms due to ddrug3 , has been reported to lower serum ddrug4 levels .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "concurrent use of ddrug0 and ddrug1 may lead to increased plasma ddrug2 levels .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "this increase was observed at the first test point which was the second day after starting ddrug0 , ddrug1 plasma levels returned to pre - ddrug2 values within # hours after discontinuing ddrug3 , if ddrug4 and ddrug5 are to be used concurrently , ddrug6 blood levels should be monitored , particularly when the ddrug7 dose is changed .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "this increase was observed at the first test point which was the second day after starting ddrug0 , ddrug1 plasma levels returned to pre - ddrug2 values within # hours after discontinuing ddrug3 , if ddrug4 and ddrug5 are to be used concurrently , ddrug6 blood levels should be monitored , particularly when the ddrug7 dose is changed .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "additionally , in one controlled study in five normal subjects and seven patients , the clearance of ddrug0 was decreased 50 % following the administration of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 inhibits some of the liver 's ability to metabolize some other drugs - ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 inhibits some of the liver 's ability to metabolize some other drugs - ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 inhibits some of the liver 's ability to metabolize some other drugs - ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 inhibits some of the liver 's ability to metabolize some other drugs - ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 inhibits some of the liver 's ability to metabolize some other drugs - ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 auc was increased by 21 % with no effect on cmax in the presence of steady-state ddrug1 compared with ddrug2 alone .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 auc and cmax were increased by 18 % and 42 % , respectively , in the presence of steady-state ddrug1 compared with ddrug2 alone .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "patients receiving ddrug0 or ddrug1 in combination with ddrug2 should be monitored for ddrug3 or ddrug4 toxicity and ddrug5 or ddrug6 dosage should be reduced if necessary .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "patients receiving ddrug0 or ddrug1 in combination with ddrug2 should be monitored for ddrug3 or ddrug4 toxicity and ddrug5 or ddrug6 dosage should be reduced if necessary .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when ddrug0 is administered concomitantly with drugs that are known to inhibit the cyp3a4 enzyme system { ie , some drugs in the drug classes of ddrug1 , ddrug2 , ddrug3 , and ddrug4 } .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when ddrug0 is administered concomitantly with drugs that are known to inhibit the cyp3a4 enzyme system { ie , some drugs in the drug classes of ddrug1 , ddrug2 , ddrug3 , and ddrug4 } .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when ddrug0 is administered concomitantly with drugs that are known to inhibit the cyp3a4 enzyme system { ie , some drugs in the drug classes of ddrug1 , ddrug2 , ddrug3 , and ddrug4 } .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when ddrug0 is administered concomitantly with drugs that are known to inhibit the cyp3a4 enzyme system { ie , some drugs in the drug classes of ddrug1 , ddrug2 , ddrug3 , and ddrug4 } .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "drugs such as ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 and ddrug5 were shown to significantly increase the c max and auc of orally administered ddrug6 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "drugs such as ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 and ddrug5 were shown to significantly increase the c max and auc of orally administered ddrug6 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "drugs such as ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 and ddrug5 were shown to significantly increase the c max and auc of orally administered ddrug6 .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "drugs such as ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 and ddrug5 were shown to significantly increase the c max and auc of orally administered ddrug6 .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "drugs such as ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 and ddrug5 were shown to significantly increase the c max and auc of orally administered ddrug6 .",
        "triple_list": [
            [
                "ddrug4",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "drugs such as ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 and ddrug5 were shown to significantly increase the c max and auc of orally administered ddrug6 .",
        "triple_list": [
            [
                "ddrug5",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "although not studied , the potent cytochrome p450 3a4 inhibitors ddrug0 and ddrug1 may cause intense and prolonged sedation and respiratory_failure due to a decrease in plasma clearance of ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "although not studied , the potent cytochrome p450 3a4 inhibitors ddrug0 and ddrug1 may cause intense and prolonged sedation and respiratory_failure due to a decrease in plasma clearance of ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "inducers of cyp3a4 isozymes : cytochrome p450 inducers , such as ddrug0 , ddrug1 , and ddrug2 , induce metabolism and caused a markedly decreased c max and auc of oral ddrug3 in adult studies .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "inducers of cyp3a4 isozymes : cytochrome p450 inducers , such as ddrug0 , ddrug1 , and ddrug2 , induce metabolism and caused a markedly decreased c max and auc of oral ddrug3 in adult studies .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "inducers of cyp3a4 isozymes : cytochrome p450 inducers , such as ddrug0 , ddrug1 , and ddrug2 , induce metabolism and caused a markedly decreased c max and auc of oral ddrug3 in adult studies .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "the sedative effect of ddrug0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the sedative effect of ddrug0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "the sedative effect of ddrug0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "the sedative effect of ddrug0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "the sedative effect of ddrug0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "the sedative effect of ddrug0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "the sedative effect of ddrug0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "the sedative effect of ddrug0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "the sedative effect of ddrug0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "when administered concomitantly with ddrug0 , ddrug1 may enhance or precipitate bradycardia , a , v.",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 or ddrug4 } may enhance or potentiate the pressor effects of ddrug5 , therefore , caution should be used when ddrug6 is administered concomitantly with agents that cause vasoconstriction .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 or ddrug4 } may enhance or potentiate the pressor effects of ddrug5 , therefore , caution should be used when ddrug6 is administered concomitantly with agents that cause vasoconstriction .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 or ddrug4 } may enhance or potentiate the pressor effects of ddrug5 , therefore , caution should be used when ddrug6 is administered concomitantly with agents that cause vasoconstriction .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 or ddrug4 } may enhance or potentiate the pressor effects of ddrug5 , therefore , caution should be used when ddrug6 is administered concomitantly with agents that cause vasoconstriction .",
        "triple_list": [
            [
                "ddrug3",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 or ddrug4 } may enhance or potentiate the pressor effects of ddrug5 , therefore , caution should be used when ddrug6 is administered concomitantly with agents that cause vasoconstriction .",
        "triple_list": [
            [
                "ddrug4",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "triple_list": [
            [
                "ddrug3",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "triple_list": [
            [
                "ddrug4",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "triple_list": [
            [
                "ddrug6",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "triple_list": [
            [
                "ddrug6",
                "mechanism",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "triple_list": [
            [
                "ddrug6",
                "mechanism",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "triple_list": [
            [
                "ddrug6",
                "mechanism",
                "ddrug10"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "triple_list": [
            [
                "ddrug6",
                "mechanism",
                "ddrug11"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "triple_list": [
            [
                "ddrug6",
                "mechanism",
                "ddrug12"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "triple_list": [
            [
                "ddrug6",
                "mechanism",
                "ddrug13"
            ]
        ]
    },
    {
        "text": "although specific drug or food interactions with ddrug0 have not been studied , on the basis of this drug s metabolism by ppig 3a4 , it is possible that ddrug1 , ddrug2 , ddrug3 , and grapefruit juice may inhibit its metabolism { increasing serum levels of ddrug4 } .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "although specific drug or food interactions with ddrug0 have not been studied , on the basis of this drug s metabolism by ppig 3a4 , it is possible that ddrug1 , ddrug2 , ddrug3 , and grapefruit juice may inhibit its metabolism { increasing serum levels of ddrug4 } .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "although specific drug or food interactions with ddrug0 have not been studied , on the basis of this drug s metabolism by ppig 3a4 , it is possible that ddrug1 , ddrug2 , ddrug3 , and grapefruit juice may inhibit its metabolism { increasing serum levels of ddrug4 } .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "john s wort , and certain ddrug0 { ddrug1 , ddrug2 , ddrug3 } may induce ddrug4 metabolism { lowering serum levels of ddrug5 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "john s wort , and certain ddrug0 { ddrug1 , ddrug2 , ddrug3 } may induce ddrug4 metabolism { lowering serum levels of ddrug5 } .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "john s wort , and certain ddrug0 { ddrug1 , ddrug2 , ddrug3 } may induce ddrug4 metabolism { lowering serum levels of ddrug5 } .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "john s wort , and certain ddrug0 { ddrug1 , ddrug2 , ddrug3 } may induce ddrug4 metabolism { lowering serum levels of ddrug5 } .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "while co-administration of ddrug0 appeared to increase the clearance of ddrug1 by 70 % , these results are not conclusive because of the small number of subjects studied and because patients took variable doses of ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "combination therapy with ddrug0 { ddrug1 } and ddrug2 is not indicated .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "combination therapy with ddrug0 { ddrug1 } and ddrug2 is not indicated .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "because ddrug0 have been shown to depress plasma prothrombin activity , patients who are on ddrug1 therapy may require downward adjustment of their ddrug2 dosage .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "since bacteriostatic drugs may interfere with the bactericidal action of ddrug0 , it is advisable to avoid giving ddrug1 in conjunction with ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "absorption of ddrug0 is impaired by ddrug1 containing ddrug2 , ddrug3 or ddrug4 , and ddrug5 - containing preparations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "absorption of ddrug0 is impaired by ddrug1 containing ddrug2 , ddrug3 or ddrug4 , and ddrug5 - containing preparations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "absorption of ddrug0 is impaired by ddrug1 containing ddrug2 , ddrug3 or ddrug4 , and ddrug5 - containing preparations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "absorption of ddrug0 is impaired by ddrug1 containing ddrug2 , ddrug3 or ddrug4 , and ddrug5 - containing preparations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "the concurrent use of ddrug0 and ddrug1 has been reported to result in fatal renal toxicity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "concurrent use of ddrug0 with oral ddrug1 may render oral ddrug2 less effective .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "interaction with ddrug0 : although ddrug1 does not itself cause orthostatic hypotension , its administration to patients already receiving ddrug2 can result in profound orthostatic effects .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "if at all possible ddrug0 should be discontinued well before ddrug1 is begun .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : concomitant administration of ddrug1 { equivalent to # g } had a minimal effect on plasma levels of ddrug2 { 15 mg } in # healthy male subjects .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "however , the impairment of cognitive and motor skills produced by ddrug0 were shown to be additive with those produced by ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "accordingly , patients should be advised to avoid ddrug0 while taking ddrug1 , ddrug2 : concomitant administration of ddrug3 { 15 mg } had a minimal effect on plasma levels of ddrug4 { 15 mg } in # healthy subjects .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "accordingly , patients should be advised to avoid ddrug0 while taking ddrug1 , ddrug2 : concomitant administration of ddrug3 { 15 mg } had a minimal effect on plasma levels of ddrug4 { 15 mg } in # healthy subjects .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "however , the impairment of motor skills produced by ddrug0 has been shown to be additive with those caused by ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "accordingly , patients should be advised to avoid ddrug0 and other similar drugs while taking ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 has been reported to accelerate the metabolism of ddrug1 by the mechanism of hepatic microsomal enzyme induction , leading to an increase in dosage requirements for ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "therefore , physicians should closely monitor patients for a change in ddrug0 dosage requirements when administering ddrug1 to patients on ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "prior administration of ddrug0 can potentiate the neuromuscular blocking effects of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "evidence of spontaneous recovery from ddrug0 should be observed before the administration of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug10"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug11"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug12"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug13"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug14"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug15"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug10"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug11"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug12"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug13"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug14"
            ]
        ]
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug15"
            ]
        ]
    },
    {
        "text": "the neuromuscular blocking effect of ddrug0 may be enhanced by drugs that reduce plasma bche activity { e , g , , chronically administered oral ddrug1 , ddrug2 , or certain ddrug3 } or by drugs that irreversibly inhibit plasma bche , resistance to the neuromuscular blocking action of nondepolarizing ddrug4 has been demonstrated in patients chronically administered ddrug5 or ddrug6 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the neuromuscular blocking effect of ddrug0 may be enhanced by drugs that reduce plasma bche activity { e , g , , chronically administered oral ddrug1 , ddrug2 , or certain ddrug3 } or by drugs that irreversibly inhibit plasma bche , resistance to the neuromuscular blocking action of nondepolarizing ddrug4 has been demonstrated in patients chronically administered ddrug5 or ddrug6 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "the neuromuscular blocking effect of ddrug0 may be enhanced by drugs that reduce plasma bche activity { e , g , , chronically administered oral ddrug1 , ddrug2 , or certain ddrug3 } or by drugs that irreversibly inhibit plasma bche , resistance to the neuromuscular blocking action of nondepolarizing ddrug4 has been demonstrated in patients chronically administered ddrug5 or ddrug6 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "the neuromuscular blocking effect of ddrug0 may be enhanced by drugs that reduce plasma bche activity { e , g , , chronically administered oral ddrug1 , ddrug2 , or certain ddrug3 } or by drugs that irreversibly inhibit plasma bche , resistance to the neuromuscular blocking action of nondepolarizing ddrug4 has been demonstrated in patients chronically administered ddrug5 or ddrug6 .",
        "triple_list": [
            [
                "ddrug4",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "the neuromuscular blocking effect of ddrug0 may be enhanced by drugs that reduce plasma bche activity { e , g , , chronically administered oral ddrug1 , ddrug2 , or certain ddrug3 } or by drugs that irreversibly inhibit plasma bche , resistance to the neuromuscular blocking action of nondepolarizing ddrug4 has been demonstrated in patients chronically administered ddrug5 or ddrug6 .",
        "triple_list": [
            [
                "ddrug4",
                "effect",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "while the effects of chronic ddrug0 or ddrug1 therapy on the action of ddrug2 are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "while the effects of chronic ddrug0 or ddrug1 therapy on the action of ddrug2 are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , ddrug3 } or ddrug4 supplements concomitantly with ddrug5 can increase the risk of hyperkalemia .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , ddrug3 } or ddrug4 supplements concomitantly with ddrug5 can increase the risk of hyperkalemia .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , ddrug3 } or ddrug4 supplements concomitantly with ddrug5 can increase the risk of hyperkalemia .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , ddrug3 } or ddrug4 supplements concomitantly with ddrug5 can increase the risk of hyperkalemia .",
        "triple_list": [
            [
                "ddrug3",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , ddrug3 } or ddrug4 supplements concomitantly with ddrug5 can increase the risk of hyperkalemia .",
        "triple_list": [
            [
                "ddrug4",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 : increased serum ddrug1 levels and symptoms of ddrug2 toxicity have been reported in patients receiving ddrug3 during therapy with ddrug4 .",
        "triple_list": [
            [
                "ddrug3",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "if a ddrug0 is also used , the risk of ddrug1 toxicity may be increased .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "however , ddrug0 , a potent inhibitor of cytochrome p450 3a4 , may increase plasma levels of ddrug1 during concomitant dosing .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as ddrug0 or ddrug1 , are co-administered with ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as ddrug0 or ddrug1 , are co-administered with ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as ddrug0 or ddrug1 , are co-administered with ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as ddrug0 or ddrug1 , are co-administered with ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "use with other ddrug0 : the depressant effects of ddrug1 are potentiated by the presence of other ddrug2 such as ddrug3 , ddrug4 , ddrug5 , or ddrug6 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "use with other ddrug0 : the depressant effects of ddrug1 are potentiated by the presence of other ddrug2 such as ddrug3 , ddrug4 , ddrug5 , or ddrug6 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "use with other ddrug0 : the depressant effects of ddrug1 are potentiated by the presence of other ddrug2 such as ddrug3 , ddrug4 , ddrug5 , or ddrug6 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "use with other ddrug0 : the depressant effects of ddrug1 are potentiated by the presence of other ddrug2 such as ddrug3 , ddrug4 , ddrug5 , or ddrug6 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "use with other ddrug0 : the depressant effects of ddrug1 are potentiated by the presence of other ddrug2 such as ddrug3 , ddrug4 , ddrug5 , or ddrug6 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "use of ddrug0 in conjunction with oral ddrug1 may increase the risk of respiratory depression , hypotension and profound sedation or coma .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "interaction with ddrug0 : ddrug1 { i , e , , ddrug2 , ddrug3 , ddrug4 , or ddrug5 } should not be administered to patients who have received or are receiving a course of therapy with a proof ddrug6 .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "interaction with ddrug0 : ddrug1 { i , e , , ddrug2 , ddrug3 , ddrug4 , or ddrug5 } should not be administered to patients who have received or are receiving a course of therapy with a proof ddrug6 .",
        "triple_list": [
            [
                "ddrug2",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "interaction with ddrug0 : ddrug1 { i , e , , ddrug2 , ddrug3 , ddrug4 , or ddrug5 } should not be administered to patients who have received or are receiving a course of therapy with a proof ddrug6 .",
        "triple_list": [
            [
                "ddrug3",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "interaction with ddrug0 : ddrug1 { i , e , , ddrug2 , ddrug3 , ddrug4 , or ddrug5 } should not be administered to patients who have received or are receiving a course of therapy with a proof ddrug6 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "interaction with ddrug0 : ddrug1 { i , e , , ddrug2 , ddrug3 , ddrug4 , or ddrug5 } should not be administered to patients who have received or are receiving a course of therapy with a proof ddrug6 .",
        "triple_list": [
            [
                "ddrug5",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 : absorption of a single dose of ddrug1 was decreased when administered to # stable renal transplant patients also taking ddrug2 - ddrug3 containing ddrug4 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when ddrug5 was administered alone under fasting conditions .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : absorption of a single dose of ddrug1 was decreased when administered to # stable renal transplant patients also taking ddrug2 - ddrug3 containing ddrug4 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when ddrug5 was administered alone under fasting conditions .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "it is recommended that ddrug0 and ddrug1 not be administered simultaneously .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 / ddrug1 : given that ddrug2 and ddrug3 inhibit purine metabolism , it is recommended that ddrug4 not be administered concomitantly with ddrug5 or ddrug6 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 / ddrug1 : given that ddrug2 and ddrug3 inhibit purine metabolism , it is recommended that ddrug4 not be administered concomitantly with ddrug5 or ddrug6 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "therefore , do not administer ddrug0 with ddrug1 or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile_acid sequestrates or oral ddrug2 , because of the potential to reduce the efficacy of ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "therefore , do not administer ddrug0 with ddrug1 or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile_acid sequestrates or oral ddrug2 , because of the potential to reduce the efficacy of ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "however , in a drug-drug interaction study , mean ddrug0 auc was decreased by 15 % when coadministered with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "therefore , it is recommended that oral ddrug0 are co - administered with ddrug1 with caution and additional birth control methods be considered .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : during treatment with ddrug1 , the use of ddrug2 should be avoided and patients should be advised that vaccinations may be less effective .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , and ddrug2 : in patients treated with potent inducers of cyp3a4 { i , e , , ddrug3 , ddrug4 , and ddrug5 } , the clearance of ddrug6 was significantly increased and ddrug7 blood concentrations were decreased .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , and ddrug2 : in patients treated with potent inducers of cyp3a4 { i , e , , ddrug3 , ddrug4 , and ddrug5 } , the clearance of ddrug6 was significantly increased and ddrug7 blood concentrations were decreased .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , and ddrug2 : in patients treated with potent inducers of cyp3a4 { i , e , , ddrug3 , ddrug4 , and ddrug5 } , the clearance of ddrug6 was significantly increased and ddrug7 blood concentrations were decreased .",
        "triple_list": [
            [
                "ddrug4",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , and ddrug2 : in patients treated with potent inducers of cyp3a4 { i , e , , ddrug3 , ddrug4 , and ddrug5 } , the clearance of ddrug6 was significantly increased and ddrug7 blood concentrations were decreased .",
        "triple_list": [
            [
                "ddrug4",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , and ddrug2 : in patients treated with potent inducers of cyp3a4 { i , e , , ddrug3 , ddrug4 , and ddrug5 } , the clearance of ddrug6 was significantly increased and ddrug7 blood concentrations were decreased .",
        "triple_list": [
            [
                "ddrug5",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 , ddrug1 , and ddrug2 : in patients treated with potent inducers of cyp3a4 { i , e , , ddrug3 , ddrug4 , and ddrug5 } , the clearance of ddrug6 was significantly increased and ddrug7 blood concentrations were decreased .",
        "triple_list": [
            [
                "ddrug5",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "however , on the basis of available data , no dosage adjustment for ddrug0 is recommended for patients on these drugs # ,3 ddrug1 : although no pharmacokinetic drug interaction between ddrug2 and ddrug3 has been observed , data from # small studies indicate that ddrug4 may be associated with an increase in patient controlled administration of ddrug5 # ,5 chemotherapy : tumor response to chemotherapy in the p # mouse leukemia model is not affected by ddrug6 .",
        "triple_list": [
            [
                "ddrug4",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "other ddrug0 should not be used concomitantly with ddrug1 { ddrug2 usp } because they may have additive effects .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "other ddrug0 should not be used concomitantly with ddrug1 { ddrug2 usp } because they may have additive effects .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 should be administered with caution to patients being treated with ddrug1 or ddrug2 , since the action of ddrug3 on the vascular system may be potentiated .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 should be administered with caution to patients being treated with ddrug1 or ddrug2 , since the action of ddrug3 on the vascular system may be potentiated .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : preliminary data from a ddrug1 and ddrug2 drug interaction study indicate a reduction in ddrug3 plasma levels when ddrug4 was coadministered with ddrug5 .",
        "triple_list": [
            [
                "ddrug4",
                "mechanism",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 and analogues : a pharmacokinetic interaction study showed a 30 % reduction in ddrug1 supplement absorption when concomitantly administered with ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 inhibited absorption of a ddrug1 supplement by approximately 60 % .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "therefore , as ddrug0 absorption may be decreased with ddrug1 , patients on chronic stable doses of ddrug2 who are prescribed ddrug3 should be monitored closely for changes in coagulation parameters .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "therefore , as ddrug0 absorption may be decreased with ddrug1 , patients on chronic stable doses of ddrug2 who are prescribed ddrug3 should be monitored closely for changes in coagulation parameters .",
        "triple_list": [
            [
                "ddrug2",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 , a bacteriostatic ddrug1 , may antagonize the bactericidal effect of ddrug2 and concurrent use of these drugs should be avoided .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "increases of ddrug0 plasma concentrations by approximately 20 % have been observed with doses of # mg/m2 ddrug1 dosed every # weeks .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 ddrug1 may increase sensitivity to oral ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : a multidose study of ddrug1 , given as # or # mg bid in # healthy subjects concurrently treated with ddrug2 , resulted in a mean increase in ddrug3 half-life from # to # hours and auc from # to # ng * hr/ml : similar increases in ddrug4 half-life and auc were also detected .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "when ddrug0 therapy is initiated in a patient already receiving treatment with ddrug1 , the inr or prothrombin time { pt } should be monitored closely and the dose of ddrug2 adjusted as necessary until a stable target inr or pt has been achieved .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "furthermore , in patients receiving both drugs , careful monitoring of the inr or pt , and adjustment of the ddrug0 dosage if indicated are recommended when the ddrug1 dose is changed or discontinued .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "oral ddrug0 ddrug1 may inhibit the metabolism of oral ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "the concomitant use of ddrug0 with other ddrug1 or with other agents which produce dry mouth , constipation , somnolence { drowsiness } , and/or other anticholinergic-like effects may increase the frequency and/or severity of such effects .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "mean ddrug0 plasma concentrations were approximately # fold higher when ddrug1 was administered with ddrug2 , a potent cyp3a4 inhibitor .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , ddrug1 and ddrug2 } or ddrug3 { e , g , , ddrug4 and ddrug5 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , ddrug1 and ddrug2 } or ddrug3 { e , g , , ddrug4 and ddrug5 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , ddrug1 and ddrug2 } or ddrug3 { e , g , , ddrug4 and ddrug5 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , ddrug1 and ddrug2 } or ddrug3 { e , g , , ddrug4 and ddrug5 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , ddrug1 and ddrug2 } or ddrug3 { e , g , , ddrug4 and ddrug5 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "triple_list": [
            [
                "ddrug4",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , ddrug1 and ddrug2 } or ddrug3 { e , g , , ddrug4 and ddrug5 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "triple_list": [
            [
                "ddrug5",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "the cns depressant effects of ddrug0 may be additive with that of other ddrug1 , .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 or other medications with anticholinergic activity when used concurrently with ddrug1 may result in increased risk of urinary retention and/or severe constipation , which may lead to paralytic ileus .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "it has been reported that the incidence of bradycardia was increased when ddrug0 was combined with ddrug1 for induction of anesthesia .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in addition , cns toxicity has been reported { confusion , disorientation , respiratory depression , apnea , seizures } following coadministration of ddrug0 with ddrug1 ;",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "given the primary cns effects of ddrug0 , ddrug1 should be used with caution in combination with other ddrug2 and ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "given the primary cns effects of ddrug0 , ddrug1 should be used with caution in combination with other ddrug2 and ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "given the primary cns effects of ddrug0 , ddrug1 should be used with caution in combination with other ddrug2 and ddrug3 .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "given the primary cns effects of ddrug0 , ddrug1 should be used with caution in combination with other ddrug2 and ddrug3 .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 may antagonize the effect of ddrug1 and other ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may antagonize the effect of ddrug1 and other ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "there have been postmarketing reports of increased inr and prothrombin time in patients receiving ddrug0 , including ddrug1 , and ddrug2 concomitantly .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "there have been postmarketing reports of increased inr and prothrombin time in patients receiving ddrug0 , including ddrug1 , and ddrug2 concomitantly .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "patients treated with ddrug0 and ddrug1 concomitantly should be monitored for increases in inr and prothrombin time .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "because of profound and long lasting inhibition of gastric acid secretion , ddrug0 may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability { eg , ddrug1 , ddrug2 esters , and ddrug3 salts } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "because of profound and long lasting inhibition of gastric acid secretion , ddrug0 may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability { eg , ddrug1 , ddrug2 esters , and ddrug3 salts } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "because of profound and long lasting inhibition of gastric acid secretion , ddrug0 may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability { eg , ddrug1 , ddrug2 esters , and ddrug3 salts } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug10"
            ]
        ]
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug11"
            ]
        ]
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug12"
            ]
        ]
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug13"
            ]
        ]
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug14"
            ]
        ]
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug15"
            ]
        ]
    },
    {
        "text": "dose adjustment of ddrug0 capsules may be required , and ipth and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong cyp3a4 inhibitor such as ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "drugs that impair intestinal absorption of ddrug0 , such as ddrug1 , may interfere with the absorption of ddrug2 capsules .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "drugs that impair intestinal absorption of ddrug0 , such as ddrug1 , may interfere with the absorption of ddrug2 capsules .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "patients receiving ddrug0 and ddrug1 should have more frequent monitoring of neutrophil counts .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in a pharmacokinetic study of # chronic hepatitis c patients concomitantly receiving ddrug0 , treatment with ddrug1 once weekly for # weeks was associated with a mean increase of 16 % in ddrug2 auc ;",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "acromegalic patients with diabetes mellitus being treated with ddrug0 and/or oral ddrug1 agents may require dose reductions of these therapeutic agents after the initiation of therapy with ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "acromegalic patients with diabetes mellitus being treated with ddrug0 and/or oral ddrug1 agents may require dose reductions of these therapeutic agents after the initiation of therapy with ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "in clinical studies , patients on ddrug0 often needed higher serum ddrug1 concentrations to achieve appropriate igf1 suppression compared with patients not receiving ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "concomitant administration of substances that are also tubularly secreted { e , g , , ddrug0 } could potentially result in delayed clearance of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "although ddrug0 { 400 mg qid } can be administered with ddrug1 in patients with normal renal function { creatinine clearance # ml/min } , caution should be used when administering ddrug2 concurrently with ddrug3 to patients with mild to moderate renal insufficiency { creatinine clearance from # to # ml/min } .",
        "triple_list": [
            [
                "ddrug2",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "patients with mild to moderate renal insufficiency should avoid taking ddrug0 with short elimination half-lives for a period of # days before , the day of , and # days following administration of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in the absence of data regarding potential interaction between ddrug0 and ddrug1 with longer half-lives , all patients taking these ddrug2 should interrupt dosing for at least # days before , the day of , and # days following ddrug3 administration .",
        "triple_list": [
            [
                "ddrug2",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "decreased seizure threshold has been reported in patients receiving ddrug0 concomitantly with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "concurrent administration of ddrug0 { e , g , , ddrug1 , ddrug2 } may diminish the bactericidal effects of ddrug3 by slowing the rate of bacterial growth .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "concurrent administration of ddrug0 { e , g , , ddrug1 , ddrug2 } may diminish the bactericidal effects of ddrug3 by slowing the rate of bacterial growth .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "concurrent administration of ddrug0 { e , g , , ddrug1 , ddrug2 } may diminish the bactericidal effects of ddrug3 by slowing the rate of bacterial growth .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 blood levels may be prolonged by concurrent administration of ddrug1 which blocks the renal tubular secretion of ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "usage with ddrug0 : due to the potential for increased cns depressants effects , ddrug1 should be used with caution in patients who are currently receiving ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "although a causal relationship has not been established , there have been reports of bleeding and/or prolonged prothrombin time in patients treated with ddrug0 with and without ddrug1 or ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "although a causal relationship has not been established , there have been reports of bleeding and/or prolonged prothrombin time in patients treated with ddrug0 with and without ddrug1 or ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "concomitant administration of ddrug0 and ddrug1 - containing drugs leads to increased ddrug2 levels and ddrug3 toxicity in some individuals .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "triple_list": [
            [
                "ddrug2",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "triple_list": [
            [
                "ddrug3",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "triple_list": [
            [
                "ddrug5",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 : patients on ddrug1 , and especially those started recently , may occasionally experience an excessive reduction of blood pressure after initiation of ddrug2 tablets therapy .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "the possibility of hypotensive effects can be minimized by either discontinuing the ddrug0 or increasing the salt intake prior to initiation of treatment with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "if ddrug0 can not be interrupted , close medical supervision should be provided with the first dose of ddrug1 tablets , for at least two hours and until blood pressure has stabilized for another hour .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : a controlled pharmacokinetic study has shown no effect on plasma ddrug1 concentrations when coadministered with ddrug2 tablets , but an effect of ddrug3 on the plasma concentration of ddrug4 / ddrug5 has not been excluded .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 : a controlled pharmacokinetic study has shown no effect on plasma ddrug1 concentrations when coadministered with ddrug2 tablets , but an effect of ddrug3 on the plasma concentration of ddrug4 / ddrug5 has not been excluded .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 : animal data have suggested the possibility of interaction between ddrug1 and ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "concomitant use of ddrug0 with ddrug1 may result in an adverse drug interaction .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 , particularly ddrug1 , may cause serious cardiac arrhythmias during ddrug2 anesthesia and therefore should be used only with great caution or not at all .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 , particularly ddrug1 , may cause serious cardiac arrhythmias during ddrug2 anesthesia and therefore should be used only with great caution or not at all .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : the pressor effect of ddrug1 is markedly potentiated in patients receiving ddrug2 { ddrug3 } .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : the pressor effect of ddrug1 is markedly potentiated in patients receiving ddrug2 { ddrug3 } .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "the pressor response of ddrug0 may also be potentiated by ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 , particularly ddrug1 , may cause serious cardiac arrhythmias during ddrug2 anesthesia and therefore should be used only with great caution or not at all .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 , particularly ddrug1 , may cause serious cardiac arrhythmias during ddrug2 anesthesia and therefore should be used only with great caution or not at all .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 - the pressor effect of ddrug1 is markedly potentiated in patients receiving ddrug2 { ddrug3 } .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 - the pressor effect of ddrug1 is markedly potentiated in patients receiving ddrug2 { ddrug3 } .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "the pressor response of ddrug0 may also be potentiated by ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 should be administered with caution to patients taking ddrug1 because of the possibility of conduction disturbances .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "catecholamine-depleting drugs { e , g , , ddrug0 } may have an additive effect when given with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 has been shown to increase serum ddrug1 levels when both drugs are co-administered .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "other ddrug0 should not be used concomitantly with ddrug1 because they may have additive effects .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "although this has not occurred in in vitro studies with ddrug0 , interactions with ddrug1 have been reported with ddrug2 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering ddrug3 to patients on ddrug4 and other highly protein-bound drugs .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "although this has not occurred in in vitro studies with ddrug0 , interactions with ddrug1 have been reported with ddrug2 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering ddrug3 to patients on ddrug4 and other highly protein-bound drugs .",
        "triple_list": [
            [
                "ddrug3",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "triple_list": [
            [
                "ddrug5",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "triple_list": [
            [
                "ddrug6",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "it is recommended that plasma ddrug0 levels be monitored when initiating , adjusting and discontinuing ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "when ddrug0 and ddrug1 are used together , the signs of atropinization { flushing , mydriasis , tachycardia , dryness of the mouth and nose } may occur earlier than might be expected when ddrug2 is used alone .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "2 - # the following precautions should be kept in mind in the treatment of anticholinesterase poisoning , although they do not bear directly on the use of ddrug0 : since ddrug1 are potentiated by the ddrug2 , they should be used cautiously in the treatment of convulsions ;",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 , a known inhibitor of renal tubular secretion of organic bases via the cationic transport system , caused a 50 % increase in ddrug2 auc and a 40 % increase in half-life { n = 12 } .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "triple_list": [
            [
                "ddrug4",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "triple_list": [
            [
                "ddrug5",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "triple_list": [
            [
                "ddrug6",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "triple_list": [
            [
                "ddrug8",
                "mechanism",
                "ddrug13"
            ]
        ]
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "triple_list": [
            [
                "ddrug9",
                "mechanism",
                "ddrug13"
            ]
        ]
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "triple_list": [
            [
                "ddrug10",
                "mechanism",
                "ddrug13"
            ]
        ]
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "triple_list": [
            [
                "ddrug11",
                "mechanism",
                "ddrug13"
            ]
        ]
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "triple_list": [
            [
                "ddrug12",
                "mechanism",
                "ddrug13"
            ]
        ]
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "triple_list": [
            [
                "ddrug3",
                "effect",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "triple_list": [
            [
                "ddrug4",
                "effect",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "triple_list": [
            [
                "ddrug5",
                "effect",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "triple_list": [
            [
                "ddrug6",
                "effect",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "triple_list": [
            [
                "ddrug7",
                "effect",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "triple_list": [
            [
                "ddrug8",
                "effect",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "due to its effects on gastric emptying , ddrug0 therapy should not be considered for patients taking drugs that alter gastrointestinal motility { e , g , , ddrug1 such as ddrug2 } and agents that slow the intestinal absorption of nutrients { e , g , , ddrug3 } .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "due to its effects on gastric emptying , ddrug0 therapy should not be considered for patients taking drugs that alter gastrointestinal motility { e , g , , ddrug1 such as ddrug2 } and agents that slow the intestinal absorption of nutrients { e , g , , ddrug3 } .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "due to its effects on gastric emptying , ddrug0 therapy should not be considered for patients taking drugs that alter gastrointestinal motility { e , g , , ddrug1 such as ddrug2 } and agents that slow the intestinal absorption of nutrients { e , g , , ddrug3 } .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "when the rapid onset of a concomitant orally administered agent is a critical determinant of effectiveness { such as ddrug0 } , the agent should be administered at least # hour prior to or # hours after ddrug1 injection .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "mixing ddrug0 and ddrug1 the pharmacokinetic parameters of ddrug2 were altered when mixed with regular , nph , and 70/30 premixed formulations of recombinant ddrug3 immediately prior to injection .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 and ddrug2 may increase the clearance of ddrug3 and may require increases in ddrug4 dose to achieve the desired response .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 and ddrug2 may increase the clearance of ddrug3 and may require increases in ddrug4 dose to achieve the desired response .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 and ddrug2 may increase the clearance of ddrug3 and may require increases in ddrug4 dose to achieve the desired response .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 and ddrug2 may increase the clearance of ddrug3 and may require increases in ddrug4 dose to achieve the desired response .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 and ddrug2 may increase the clearance of ddrug3 and may require increases in ddrug4 dose to achieve the desired response .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 and ddrug2 may increase the clearance of ddrug3 and may require increases in ddrug4 dose to achieve the desired response .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "drugs such as ddrug0 and ddrug1 may inhibit the metabolism of ddrug2 and thus decrease their clearance .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "drugs such as ddrug0 and ddrug1 may inhibit the metabolism of ddrug2 and thus decrease their clearance .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may increase the clearance of chronic high dose ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "this could lead to decreased ddrug0 serum levels or increase the risk of ddrug1 toxicity when ddrug2 is withdrawn .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 should be used cautiously in conjunction with ddrug1 in patients suffering from hypoprothrombinemia .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the effect of ddrug0 on oral ddrug1 is variable .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "there are reports of enhanced as well as diminished effects of ddrug0 when given concurrently with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : concurrent use of ddrug1 and ddrug2 may result in increased systemic toxicity since ddrug3 inhibit the breakdown of ddrug4 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : concurrent use of ddrug1 and ddrug2 may result in increased systemic toxicity since ddrug3 inhibit the breakdown of ddrug4 .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 medications : concurrent use of ddrug1 and ddrug2 may result in additive depressant effects .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 may increase the diffusion rate of ddrug2 , resulting in a decreased time of onset , but an increase in systemic toxicity .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 { such as ddrug1 } : concurrent use of ddrug2 and ddrug3 may result in prolongation or enhancement of the neuromuscular blockade .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 : concurrent use of ddrug1 and ddrug2 may result in a reduction of the antibacterial action of the ddrug3 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : concurrent use of ddrug1 and ddrug2 may extend the plasma half-life of ddrug3 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , ddrug1 , ddrug2 drugs { e , g , , ddrug3 , ddrug4 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , ddrug1 , ddrug2 drugs { e , g , , ddrug3 , ddrug4 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , ddrug1 , ddrug2 drugs { e , g , , ddrug3 , ddrug4 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , ddrug1 , ddrug2 drugs { e , g , , ddrug3 , ddrug4 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , ddrug1 , ddrug2 drugs { e , g , , ddrug3 , ddrug4 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 may accentuate the orthostatic hypotension that may occur with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "antihypertensive effects of ddrug0 and related compounds may be counteracted when ddrug1 are used concomitantly .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "concomitant administration of ddrug0 with ddrug1 results in increased plasma levels of both drugs .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the induction dose requirements of ddrug0 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with ddrug1 { eg , ddrug2 , ddrug3 , and ddrug4 , etc. .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the induction dose requirements of ddrug0 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with ddrug1 { eg , ddrug2 , ddrug3 , and ddrug4 , etc. .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "the induction dose requirements of ddrug0 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with ddrug1 { eg , ddrug2 , ddrug3 , and ddrug4 , etc. .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "the induction dose requirements of ddrug0 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with ddrug1 { eg , ddrug2 , ddrug3 , and ddrug4 , etc. .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "during maintenance of anesthesia or sedation , the rate of ddrug0 injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental ddrug1 { eg , ddrug2 or ddrug3 } .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "during maintenance of anesthesia or sedation , the rate of ddrug0 injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental ddrug1 { eg , ddrug2 or ddrug3 } .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "during maintenance of anesthesia or sedation , the rate of ddrug0 injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental ddrug1 { eg , ddrug2 or ddrug3 } .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "the cns-depressant effect of ddrug0 is additive with that of other ddrug1 , including ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the cns-depressant effect of ddrug0 is additive with that of other ddrug1 , including ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 increase the effects of ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 increase the effects of ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may reduce the antihypertensive effects of ddrug1 , ddrug2 , ddrug3 and ddrug4 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may reduce the antihypertensive effects of ddrug1 , ddrug2 , ddrug3 and ddrug4 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may reduce the antihypertensive effects of ddrug1 , ddrug2 , ddrug3 and ddrug4 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 may reduce the antihypertensive effects of ddrug1 , ddrug2 , ddrug3 and ddrug4 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "mild hepatotoxicity has been reported in some patients when ddrug0 and ddrug1 were administered concomitantly .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 causes a 60 % reduction in the absorption and enterohepatic cycling of ddrug2 and should not be coadministered with ddrug3 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : ddrug1 causes a 60 % reduction in the absorption and enterohepatic cycling of ddrug2 and should not be coadministered with ddrug3 .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "if ddrug0 is given concurrently with ddrug1 , prothrombin time should be monitored .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "caution should be used when ddrug0 is coadministered with other highly protein-bound drugs , such as ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "caution should be used when ddrug0 is coadministered with other highly protein-bound drugs , such as ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "caution should be used when ddrug0 is coadministered with other highly protein-bound drugs , such as ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "caution should be used when ddrug0 is coadministered with other highly protein-bound drugs , such as ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "caution should be used when ddrug0 is coadministered with other highly protein-bound drugs , such as ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "caution should be used when ddrug0 is coadministered with other highly protein-bound drugs , such as ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "coadministration of ddrug0 with ddrug1 resulted in increased plasma ddrug2 concentrations { 57 % } , increased plasma bismuth trough concentrations { 48 % } , and increased ddrug3 plasma concentrations { 31 % } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "coadministration with a high dose of ddrug0 { 170 meq } results in a 28 % decrease in plasma concentrations of ddrug1 and may decrease plasma concentrations of bismuth from ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "coadministration with a high dose of ddrug0 { 170 meq } results in a 28 % decrease in plasma concentrations of ddrug1 and may decrease plasma concentrations of bismuth from ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "co-administration of oral ddrug0 # mg twice daily increased ddrug1 geometric mean auc { 0-24 } and cmax by 81 % after topical application of ddrug2 ointment , 1 % on the abraded skin of healthy adult males .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "in addition to bleeding associated with ddrug0 and ddrug1 , drugs that alter platelet function { such as ddrug2 , ddrug3 , and ddrug4 } may increase the risk of bleeding if administered prior to or after ddrug5 therapy .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "in addition to bleeding associated with ddrug0 and ddrug1 , drugs that alter platelet function { such as ddrug2 , ddrug3 , and ddrug4 } may increase the risk of bleeding if administered prior to or after ddrug5 therapy .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "in addition to bleeding associated with ddrug0 and ddrug1 , drugs that alter platelet function { such as ddrug2 , ddrug3 , and ddrug4 } may increase the risk of bleeding if administered prior to or after ddrug5 therapy .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "in addition to bleeding associated with ddrug0 and ddrug1 , drugs that alter platelet function { such as ddrug2 , ddrug3 , and ddrug4 } may increase the risk of bleeding if administered prior to or after ddrug5 therapy .",
        "triple_list": [
            [
                "ddrug3",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "in addition to bleeding associated with ddrug0 and ddrug1 , drugs that alter platelet function { such as ddrug2 , ddrug3 , and ddrug4 } may increase the risk of bleeding if administered prior to or after ddrug5 therapy .",
        "triple_list": [
            [
                "ddrug4",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : ddrug2 - impairs the intestinal absorption of ddrug3",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 - concurrent use decreases gastrointestinal absorption of ddrug1 ;",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "requirements for ddrug0 may be increased in patients receiving ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "when a single # mg dose of ddrug0 was administered one hour after the initiation of ddrug1 { 300 mg four times a day } , the apparent total ddrug2 clearance of this single dose in normal healthy adults was reduced by 18 % { compared to the apparent total ddrug3 clearance in the same subjects in the absence of ddrug4 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "coadministration with ddrug0 reduced the peak concentration and auc values for ddrug1 by approximately 11 % .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "peak plasma concentrations and auc of ddrug0 were reduced approximately 10 % in the presence of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "use with ddrug0 : because of their mechanism of action , ddrug1 have the potential to interfere with the activity of ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "use with ddrug0 and other ddrug1 : a synergistic effect may be expected when ddrug2 are given concurrently with ddrug3 , similar ddrug4 or ddrug5 such as ddrug6 .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "use with ddrug0 and other ddrug1 : a synergistic effect may be expected when ddrug2 are given concurrently with ddrug3 , similar ddrug4 or ddrug5 such as ddrug6 .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "use with ddrug0 and other ddrug1 : a synergistic effect may be expected when ddrug2 are given concurrently with ddrug3 , similar ddrug4 or ddrug5 such as ddrug6 .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "use with ddrug0 and other ddrug1 : a synergistic effect may be expected when ddrug2 are given concurrently with ddrug3 , similar ddrug4 or ddrug5 such as ddrug6 .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "if ddrug0 is administered following administration of ddrug1 , it should not be given until recovery from ddrug2 has been observed .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 should be used with caution in patients receiving other local ddrug1 or agents structurally related to ddrug2 , since the toxic effects of these drugs are additive .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in vivo , the plasma clearance of ddrug0 was reduced by 70 % during coadministration of ddrug1 { 25 mg bid for # days } , a selective and potent cyp1a2 inhibitor .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "thus strong inhibitors of cytochrome p4501a2 , such as ddrug0 , given concomitantly during administration of ddrug1 , can interact with ddrug2 leading to increased ddrug3 plasma levels .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "coadministration of a selective and potent inhibitor of cyp3a4 , ddrug0 { 100 mg bid for # days with ddrug1 infusion administered # hour after ddrug2 } caused a 15 % reduction in in-vivo plasma clearance of ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "an inhibitor of cyp2c8 { such as ddrug0 } may increase the auc of ddrug1 and an inducer of cyp2c8 { such as ddrug2 } may decrease the auc of ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "an inhibitor of cyp2c8 { such as ddrug0 } may increase the auc of ddrug1 and an inducer of cyp2c8 { such as ddrug2 } may decrease the auc of ddrug3 .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "concomitant administrations not recommended : - ddrug0 and ddrug1 : certain ddrug2 interact with ddrug3 and ddrug4 leading to increased serum concentrations of the latter .",
        "triple_list": [
            [
                "ddrug2",
                "int",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "concomitant administrations not recommended : - ddrug0 and ddrug1 : certain ddrug2 interact with ddrug3 and ddrug4 leading to increased serum concentrations of the latter .",
        "triple_list": [
            [
                "ddrug2",
                "int",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "although such a reaction has not been demonstrated with ddrug0 , concomitant administration of ddrug1 with ddrug2 or ddrug3 is not recommended .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "although such a reaction has not been demonstrated with ddrug0 , concomitant administration of ddrug1 with ddrug2 or ddrug3 is not recommended .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "- ddrug0 , ddrug1 : other drugs such as ddrug2 or ddrug3 , which are metabolised by hepatic cytochrome_p450_family_3_subfamily_a isozymes have been associated with qt interval prolongation and/or cardiac arrythmias { typically torsades de pointe } as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme , including some ddrug4 .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "however , in patients with paget 's disease prior ddrug0 use appears to reduce the anti-resorptive response to ddrug1 nasal spray .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 and other ddrug1 will be additive to ddrug2 and may increase plasma concentrations of ddrug3 to toxic levels .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 and other ddrug1 will be additive to ddrug2 and may increase plasma concentrations of ddrug3 to toxic levels .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 given concomitantly with ddrug1 may predispose to systemic bleeding .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may enhance the hypoglycemic effect of oral ddrug1 of the sulfonylurea class .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug10"
            ]
        ]
    },
    {
        "text": "drugs which may potentiate the myeloproliferative effects of ddrug0 , such as ddrug1 and ddrug2 , should be used with caution .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "drugs which may potentiate the myeloproliferative effects of ddrug0 , such as ddrug1 and ddrug2 , should be used with caution .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 should be used with care in patients taking other drugs that are capable of causing cns effects such as ddrug1 , ddrug2 , or ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 should be used with care in patients taking other drugs that are capable of causing cns effects such as ddrug1 , ddrug2 , or ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 should be used with care in patients taking other drugs that are capable of causing cns effects such as ddrug1 , ddrug2 , or ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 may decrease the effectiveness of oral ddrug1 , certain ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may decrease the effectiveness of oral ddrug1 , certain ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may decrease the effectiveness of oral ddrug1 , certain ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 may decrease the effectiveness of oral ddrug1 , certain ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 may decrease the effectiveness of oral ddrug1 , certain ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 may decrease the effectiveness of oral ddrug1 , certain ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 may decrease the effectiveness of oral ddrug1 , certain ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "the occurrence of stupor , muscular rigidity , severe agitation , and elevated temperature has been reported in some patients receiving the combination of ddrug0 and ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "this is typical of the interaction of ddrug0 and ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "severe toxicity has also been reported in patients receiving the combination of ddrug0 and ddrug1 and ddrug2 and ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "one case of hypertensive crisis has been reported in a patient taking the recommended doses of ddrug0 and a ddrug1 { ddrug2 } .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "one case of hypertensive crisis has been reported in a patient taking the recommended doses of ddrug0 and a ddrug1 { ddrug2 } .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : there was a slight increase in the area under the curve { auc , 11 % } and mean peak drug concentration { cmax , 18 % } of ddrug1 with the co-administration of # mg ddrug2 for # days .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 are incompatible with ddrug2 solution .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 and ddrug1 are incompatible with ddrug2 solution .",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "do not exceed a # mg daily dose of ddrug0 when administered with therapeutic doses of ddrug1 or other potent cyp3a4 inhibitors .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "limited published data indicate that ddrug0 treatment increases cytochrome cyp2b6 { cp450 } mediated ddrug1 clearance in man .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "these data suggest that ddrug0 administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "these data suggest that ddrug0 administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "these data suggest that ddrug0 administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "these data suggest that ddrug0 administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "caution is recommended when administering ddrug0 with compounds that are metabolized/eliminated predominantly by the ugt1a1 pathway { e , g , ddrug1 } .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "concomitant treatment with ddrug0 resulted in a 21 % increase in the auc of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "caution is recommended when administering ddrug0 with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 competitively inhibits the intracellular phosphorylation of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "therefore , use of ddrug0 in combination with ddrug1 should be avoided .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in vitro data indicate that the phosphorylation of ddrug0 is also inhibited at relevant concentrations by ddrug1 and ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in vitro data indicate that the phosphorylation of ddrug0 is also inhibited at relevant concentrations by ddrug1 and ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "use of ddrug0 and ddrug1 -- ddrug2 , ddrug3 , alone or in combination with ddrug4 and ddrug5 , may cause bleeding complications .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "use of ddrug0 and ddrug1 -- ddrug2 , ddrug3 , alone or in combination with ddrug4 and ddrug5 , may cause bleeding complications .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "use of ddrug0 and ddrug1 -- ddrug2 , ddrug3 , alone or in combination with ddrug4 and ddrug5 , may cause bleeding complications .",
        "triple_list": [
            [
                "ddrug3",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "use of ddrug0 and ddrug1 -- ddrug2 , ddrug3 , alone or in combination with ddrug4 and ddrug5 , may cause bleeding complications .",
        "triple_list": [
            [
                "ddrug3",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "the addition of ddrug0 to ddrug1 causes a minimal increase in the risk of minor bleeding { # % vs , # % } , but does not appear to increase the incidence of major bleeding { see",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 has been reported to prolong the elimination half-life of ddrug1 and may lead to severe bone marrow suppression ;",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "a reduction of the ddrug0 dosage should be considered in patients receiving ddrug1 concurrently .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the concurrent use of ddrug0 and ddrug1 has been reported in one case to result in reduced ddrug2 cytotoxicity .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "concomitant administration of ddrug0 with other chelation therapy , such as ddrug1 is not recommended .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may increase the effects of ddrug1 , ddrug2 , and ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may increase the effects of ddrug1 , ddrug2 , and ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may increase the effects of ddrug1 , ddrug2 , and ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "it has been reported that ddrug0 may prolong the prothrombin time in patients who are receiving the ddrug1 ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may inhibit the hepatic metabolism of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "at a # - g dose , ddrug0 produced a slight but significant increase in the half-life of ddrug1 but did not produce a corresponding decrease in the metabolic clearance rate .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 can also displace ddrug1 from plasma protein-binding sites , thus increasing free ddrug2 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "reduced absorption of ddrug0 and ddrug1 have been reported when those agents were administered concomitantly with ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "reduced absorption of ddrug0 and ddrug1 have been reported when those agents were administered concomitantly with ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may increase the effects of ddrug1 , ddrug2 , and ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may increase the effects of ddrug1 , ddrug2 , and ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may increase the effects of ddrug1 , ddrug2 , and ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "because there is a theoretical basis that these effects may be additive , use of ddrug0 - containing or ddrug1 { like ddrug2 or ddrug3 } and ddrug4 within # hours of each other should be avoided .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "because there is a theoretical basis that these effects may be additive , use of ddrug0 - containing or ddrug1 { like ddrug2 or ddrug3 } and ddrug4 within # hours of each other should be avoided .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "because there is a theoretical basis that these effects may be additive , use of ddrug0 - containing or ddrug1 { like ddrug2 or ddrug3 } and ddrug4 within # hours of each other should be avoided .",
        "triple_list": [
            [
                "ddrug2",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "because there is a theoretical basis that these effects may be additive , use of ddrug0 - containing or ddrug1 { like ddrug2 or ddrug3 } and ddrug4 within # hours of each other should be avoided .",
        "triple_list": [
            [
                "ddrug3",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 reduce ddrug1 clearance , significantly increasing systemic exposure .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "triple_list": [
            [
                "ddrug3",
                "effect",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "triple_list": [
            [
                "ddrug4",
                "effect",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "triple_list": [
            [
                "ddrug5",
                "effect",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "triple_list": [
            [
                "ddrug6",
                "effect",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "triple_list": [
            [
                "ddrug7",
                "effect",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "if concomitant treatment with ddrug0 and an ddrug1 is clinically warranted , appropriate observation of the patient is advised .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug10"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug11"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease ddrug8 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease ddrug8 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease ddrug8 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease ddrug8 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease ddrug8 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease ddrug8 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease ddrug8 concentrations .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "other eye drops or medications such as ddrug0 { ddrug1 } and ddrug2 { ddrug3 , ddrug4 } may decrease the effects of ddrug5 ophthalmic .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "other eye drops or medications such as ddrug0 { ddrug1 } and ddrug2 { ddrug3 , ddrug4 } may decrease the effects of ddrug5 ophthalmic .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "other eye drops or medications such as ddrug0 { ddrug1 } and ddrug2 { ddrug3 , ddrug4 } may decrease the effects of ddrug5 ophthalmic .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "other eye drops or medications such as ddrug0 { ddrug1 } and ddrug2 { ddrug3 , ddrug4 } may decrease the effects of ddrug5 ophthalmic .",
        "triple_list": [
            [
                "ddrug3",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "other eye drops or medications such as ddrug0 { ddrug1 } and ddrug2 { ddrug3 , ddrug4 } may decrease the effects of ddrug5 ophthalmic .",
        "triple_list": [
            [
                "ddrug4",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "however , interactions may be expected and ddrug0 capsules should not be used in combination with other ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "therefore , ddrug0 capsules should be used with caution in combination with ddrug1 , particularly at doses higher than # mg .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "therefore , caution should be exercised with concomitant administration of ddrug0 and ddrug1 capsules .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "administration of ddrug0 decreases oral clearance of ddrug1 by about 5 % .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 { such as ddrug1 and ddrug2 } and drugs that alter platelet function { such as ddrug3 , ddrug4 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after ddrug5 therapy .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 { such as ddrug1 and ddrug2 } and drugs that alter platelet function { such as ddrug3 , ddrug4 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after ddrug5 therapy .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 { such as ddrug1 and ddrug2 } and drugs that alter platelet function { such as ddrug3 , ddrug4 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after ddrug5 therapy .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 { such as ddrug1 and ddrug2 } and drugs that alter platelet function { such as ddrug3 , ddrug4 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after ddrug5 therapy .",
        "triple_list": [
            [
                "ddrug3",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 { such as ddrug1 and ddrug2 } and drugs that alter platelet function { such as ddrug3 , ddrug4 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after ddrug5 therapy .",
        "triple_list": [
            [
                "ddrug4",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "in a study in which # different drugs were tested , therapeutically relevant concentrations of ddrug0 , ddrug1 and ddrug2 displaced protein-bound ddrug3 in fresh human serum to a small but significant extent .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "in a study in which # different drugs were tested , therapeutically relevant concentrations of ddrug0 , ddrug1 and ddrug2 displaced protein-bound ddrug3 in fresh human serum to a small but significant extent .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "in a study in which # different drugs were tested , therapeutically relevant concentrations of ddrug0 , ddrug1 and ddrug2 displaced protein-bound ddrug3 in fresh human serum to a small but significant extent .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "an increase in intracellular levels of ddrug0 was observed in vitro in the presence of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 decreases the clearance of ddrug1 by 19 % .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 increases the clearance of ddrug1 by 15 % .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "there have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral ddrug0 and ddrug1 , however , a causal relationship between ddrug2 tablets and these changes has not been established .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 clearance is increased 100 % by ddrug1 , a cyp450 enzyme inducer , and decreased 33 % by ddrug2 , a cyp450 enzyme inhibitor .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 clearance is increased 100 % by ddrug1 , a cyp450 enzyme inducer , and decreased 33 % by ddrug2 , a cyp450 enzyme inhibitor .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 : spontaneous adverse reaction reports of patients taking concomitant ddrug1 with recommended doses of ddrug2 demonstrate qt interval prolongation and rare serious cardiac events , e , g.",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "pharmacokinetic data indicate that ddrug0 markedly inhibits the metabolism of ddrug1 , resulting in elevated plasma ddrug2 levels .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "concomitant administration of ddrug0 and ddrug1 is contraindicated .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : torsades de pointes and elevated parent ddrug1 levels have been reported during concomitant use of ddrug2 and ddrug3 in clinical trials of ddrug4 and from foreign post-marketing sources .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "concomitant administration of ddrug0 and ddrug1 is contraindicated .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including ddrug1 , ddrug2 , and ddrug3 } to ddrug4 , and ddrug5 , concomitant use of these products with ddrug6 is not recommended pending full examination of potential interactions .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including ddrug1 , ddrug2 , and ddrug3 } to ddrug4 , and ddrug5 , concomitant use of these products with ddrug6 is not recommended pending full examination of potential interactions .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including ddrug1 , ddrug2 , and ddrug3 } to ddrug4 , and ddrug5 , concomitant use of these products with ddrug6 is not recommended pending full examination of potential interactions .",
        "triple_list": [
            [
                "ddrug2",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including ddrug1 , ddrug2 , and ddrug3 } to ddrug4 , and ddrug5 , concomitant use of these products with ddrug6 is not recommended pending full examination of potential interactions .",
        "triple_list": [
            [
                "ddrug3",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 : clinical drug interaction studies indicate that ddrug1 and ddrug2 can exert an effect on ddrug3 metabolism by a mechanism which may be similar to that of ddrug4 , but to a lesser extent .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 : clinical drug interaction studies indicate that ddrug1 and ddrug2 can exert an effect on ddrug3 metabolism by a mechanism which may be similar to that of ddrug4 , but to a lesser extent .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "concomitant administration of ddrug0 with ddrug1 , ddrug2 , or ddrug3 is contraindicated : pending full characterization of potential interactions , concomitant administration of ddrug4 with other ddrug5 , including ddrug6 , is not recommended .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "concomitant administration of ddrug0 with ddrug1 , ddrug2 , or ddrug3 is contraindicated : pending full characterization of potential interactions , concomitant administration of ddrug4 with other ddrug5 , including ddrug6 , is not recommended .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "concomitant administration of ddrug0 with ddrug1 , ddrug2 , or ddrug3 is contraindicated : pending full characterization of potential interactions , concomitant administration of ddrug4 with other ddrug5 , including ddrug6 , is not recommended .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "concomitant administration of ddrug0 with ddrug1 , ddrug2 , or ddrug3 is contraindicated : pending full characterization of potential interactions , concomitant administration of ddrug4 with other ddrug5 , including ddrug6 , is not recommended .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "concomitant administration of ddrug0 with ddrug1 , ddrug2 , or ddrug3 is contraindicated : pending full characterization of potential interactions , concomitant administration of ddrug4 with other ddrug5 , including ddrug6 , is not recommended .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "when administered concurrently , ddrug0 may increase the effects of oral ddrug1 ;",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 has been reported to enhance the sedative activity of ddrug1 , ddrug2 , ddrug3 , and ddrug4 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 with ddrug1 may reduce the effectiveness of the contraception and up to one month after discontinuation of these concomitant therapies .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may compete with other drugs , such as ddrug1 , for sites of metabolism in the liver , thus elevating the serum levels of such compounds to potentially toxic levels .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "therefore , when concomitant use of ddrug0 and ddrug1 is anticipated , it may be necessary to monitor blood levels and/or reduce the dosage of such compounds .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : ddrug2 , oral ddrug3 , ddrug4 , ddrug5",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : ddrug2 , oral ddrug3 , ddrug4 , ddrug5",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : ddrug2 , oral ddrug3 , ddrug4 , ddrug5",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : ddrug2 , oral ddrug3 , ddrug4 , ddrug5",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : ddrug2 , oral ddrug3 , ddrug4 , ddrug5",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : ddrug2 , oral ddrug3 , ddrug4 , ddrug5",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : ddrug2 , oral ddrug3 , ddrug4 , ddrug5",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : ddrug2 , oral ddrug3 , ddrug4 , ddrug5",
        "triple_list": [
            [
                "ddrug1",
                "int",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 are capable of potentiating ddrug1 { e , g , , ddrug2 , ddrug3 , ddrug4 , ddrug5 , etc. .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 are capable of potentiating ddrug1 { e , g , , ddrug2 , ddrug3 , ddrug4 , ddrug5 , etc. .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 are capable of potentiating ddrug1 { e , g , , ddrug2 , ddrug3 , ddrug4 , ddrug5 , etc. .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 are capable of potentiating ddrug1 { e , g , , ddrug2 , ddrug3 , ddrug4 , ddrug5 , etc. .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 are capable of potentiating ddrug1 { e , g , , ddrug2 , ddrug3 , ddrug4 , ddrug5 , etc. .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "there is usually complete cross-resistance between ddrug0 { ddrug1 } and ddrug2 brand ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "there is usually complete cross-resistance between ddrug0 { ddrug1 } and ddrug2 brand ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "there is usually complete cross-resistance between ddrug0 { ddrug1 } and ddrug2 brand ddrug3 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "there is usually complete cross-resistance between ddrug0 { ddrug1 } and ddrug2 brand ddrug3 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "as there is in vitro evidence that ddrug0 { e , g , , ddrug1 , ddrug2 , or ddrug3 } inhibit the tpmt enzyme , they should be administered with caution to patients receiving concurrent ddrug4 therapy .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "as there is in vitro evidence that ddrug0 { e , g , , ddrug1 , ddrug2 , or ddrug3 } inhibit the tpmt enzyme , they should be administered with caution to patients receiving concurrent ddrug4 therapy .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "as there is in vitro evidence that ddrug0 { e , g , , ddrug1 , ddrug2 , or ddrug3 } inhibit the tpmt enzyme , they should be administered with caution to patients receiving concurrent ddrug4 therapy .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "as there is in vitro evidence that ddrug0 { e , g , , ddrug1 , ddrug2 , or ddrug3 } inhibit the tpmt enzyme , they should be administered with caution to patients receiving concurrent ddrug4 therapy .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "caution should be exercised when administering ddrug0 therapy in combination with other ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "prothrombin time or other suitable anticoagulation test should be monitored if ddrug0 is administered with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "concurrent use of ddrug0 with oral ddrug1 may render oral ddrug2 less effective .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing ddrug6 , when administered # hour before ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing ddrug6 , when administered # hour before ddrug7 .",
        "triple_list": [
            [
                "ddrug4",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing ddrug6 , when administered # hour before ddrug7 .",
        "triple_list": [
            [
                "ddrug5",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "ddrug0 may decrease bioavailability of ddrug1 by up to 50 % when taken # hours after ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the bioavailability of ddrug0 is increased 2-4 fold by ddrug1 but is not significantly altered by coadministration of ddrug2 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "however , the co administration of ddrug0 with other ddrug1 containing drugs { e , g , , ddrug2 } has not been studied and is therefore not recommended .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "however , the co administration of ddrug0 with other ddrug1 containing drugs { e , g , , ddrug2 } has not been studied and is therefore not recommended .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "the use of ddrug0 , in combination with ddrug1 and ddrug2 , has been associated with an increase in bleeding compared to ddrug3 and ddrug4 alone { see",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "the use of ddrug0 , in combination with ddrug1 and ddrug2 , has been associated with an increase in bleeding compared to ddrug3 and ddrug4 alone { see",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "some ddrug0 can enhance ddrug1 toxicity by altering ddrug2 concentrations in serum and tissue .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 should not be administered concomitantly with ddrug1 , ddrug2 , ddrug3 , or ddrug4 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 should not be administered concomitantly with ddrug1 , ddrug2 , ddrug3 , or ddrug4 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 should not be administered concomitantly with ddrug1 , ddrug2 , ddrug3 , or ddrug4 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 should not be administered concomitantly with ddrug1 , ddrug2 , ddrug3 , or ddrug4 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "however , increased prothrombin time and bleeding have been reported in patients on concomitant ddrug0 and ddrug1 therapy .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "therefore , caution should be exercised when administering ddrug0 to patients on ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "caution should be used if ddrug0 is administered concomitantly with ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 and other ddrug1 have been reported to reduce the tubular secretion of ddrug2 in an animal model , possibly enhancing the toxicity of ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 and other ddrug1 have been reported to reduce the tubular secretion of ddrug2 in an animal model , possibly enhancing the toxicity of ddrug3 .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "cyp3a4 inhibitors : ddrug0 , an inhibitor of the drug metabolizing enzyme cyp3a4 , significantly increased plasma concentrations of ddrug1 when coadministered to subjects who were poor metabolizers { see clinical pharmacology , variability in metabolism and drug-drug interactions } .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "triple_list": [
            [
                "ddrug1",
                "advise",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "triple_list": [
            [
                "ddrug2",
                "advise",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "triple_list": [
            [
                "ddrug3",
                "advise",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "triple_list": [
            [
                "ddrug4",
                "advise",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "triple_list": [
            [
                "ddrug5",
                "advise",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "triple_list": [
            [
                "ddrug6",
                "advise",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "triple_list": [
            [
                "ddrug7",
                "advise",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "triple_list": [
            [
                "ddrug8",
                "advise",
                "ddrug9"
            ]
        ]
    },
    {
        "text": "administration of ddrug0 in combination with ddrug1 resulted in a two-fold decrease in ddrug2 clearance in a non-human primate study and in a # - fold increase in ddrug3 serum levels in clinical studies .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 or ddrug2 { causing too great a decrease in adrenal function } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may interact with ddrug1 or ddrug2 { causing too great a decrease in adrenal function } .",
        "triple_list": [
            [
                "ddrug0",
                "int",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may inhibit the hepatic metabolism of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 , given at a common clinical dosage , increased the ddrug1 half-life by 51 % and decreased the ddrug2 metabolic clearance rate by 30 % .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 , given at a common clinical dosage , increased the ddrug1 half-life by 51 % and decreased the ddrug2 metabolic clearance rate by 30 % .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "agents that might be coadministered with ddrug0 in acquired_immune_deficiency_syndrome patients for other indications that could elicit this activity include ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "agents that might be coadministered with ddrug0 in acquired_immune_deficiency_syndrome patients for other indications that could elicit this activity include ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "agents that might be coadministered with ddrug0 in acquired_immune_deficiency_syndrome patients for other indications that could elicit this activity include ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "agents that might be coadministered with ddrug0 in acquired_immune_deficiency_syndrome patients for other indications that could elicit this activity include ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "agents that might be coadministered with ddrug0 in acquired_immune_deficiency_syndrome patients for other indications that could elicit this activity include ddrug1 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "in vitro perfusion of isolated rat liver has shown that ddrug0 caused a significant reduction in ddrug1 metabolism and that ddrug2 altered the relative concentration of tmq metabolites possibly by competing for sulfate metabolites .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "based on an in vitro rat liver model , nitrogen substituted ddrug0 { ddrug1 , ddrug2 , ddrug3 } were potent , non-competitive inhibitors of ddrug4 metabolism .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "based on an in vitro rat liver model , nitrogen substituted ddrug0 { ddrug1 , ddrug2 , ddrug3 } were potent , non-competitive inhibitors of ddrug4 metabolism .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "based on an in vitro rat liver model , nitrogen substituted ddrug0 { ddrug1 , ddrug2 , ddrug3 } were potent , non-competitive inhibitors of ddrug4 metabolism .",
        "triple_list": [
            [
                "ddrug2",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "based on an in vitro rat liver model , nitrogen substituted ddrug0 { ddrug1 , ddrug2 , ddrug3 } were potent , non-competitive inhibitors of ddrug4 metabolism .",
        "triple_list": [
            [
                "ddrug3",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 may enhance the sedative effects of ddrug1 including ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 may enhance the sedative effects of ddrug1 including ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "ddrug0 may enhance the sedative effects of ddrug1 including ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "ddrug0 may enhance the sedative effects of ddrug1 including ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "ddrug0 may enhance the sedative effects of ddrug1 including ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "ddrug0 may enhance the sedative effects of ddrug1 including ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "ddrug0 may enhance the sedative effects of ddrug1 including ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "the effects of ddrug0 , such as ddrug1 and ddrug2 may be enhanced by the concomitant administration of ddrug3 .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "the effects of ddrug0 , such as ddrug1 and ddrug2 may be enhanced by the concomitant administration of ddrug3 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "the effects of ddrug0 , such as ddrug1 and ddrug2 may be enhanced by the concomitant administration of ddrug3 .",
        "triple_list": [
            [
                "ddrug2",
                "effect",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "the concomitant use of ddrug0 with other ddrug1 that produce dry mouth , constipation , and other anticholinergic pharmacological effects may increase the frequency and/or severity of such effects .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 and ddrug8 } .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 and ddrug8 } .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug3"
            ]
        ]
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 and ddrug8 } .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug4"
            ]
        ]
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 and ddrug8 } .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug5"
            ]
        ]
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 and ddrug8 } .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug6"
            ]
        ]
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 and ddrug8 } .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug7"
            ]
        ]
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 and ddrug8 } .",
        "triple_list": [
            [
                "ddrug1",
                "mechanism",
                "ddrug8"
            ]
        ]
    },
    {
        "text": "concomitant administration of ddrug0 and ddrug1 has been associated with erythema and histamine-like flushing and anaphylactoid reactions .",
        "triple_list": [
            [
                "ddrug0",
                "effect",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "a study published in # found that ddrug0 causes a statistically significant increase in plasma clearance of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "in 1984 , drs rimmer and richens at the university of wales reported that administering ddrug0 with ddrug1 lowered the serum ddrug2 concentration in patients with treatment-resistant epilepsy .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "drug interactions : women on oral ddrug0 have shown a significant increase in plasma ddrug1 levels .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "limited evidence suggests that ddrug0 may influence the intensity and duration of action of ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "mechanism",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "ddrug0 : prolongation of prothrombin time { pt } and international normalized ratio { inr } were observed in patients receiving ddrug1 concomitantly with ddrug2 .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "physicians should carefully monitor pt and inr in patients concurrently administered ddrug0 and ddrug1 .",
        "triple_list": [
            [
                "ddrug0",
                "advise",
                "ddrug1"
            ]
        ]
    },
    {
        "text": "other ddrug0 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of ddrug1 and other ddrug2 { e , g , , ddrug3 } .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug2"
            ]
        ]
    },
    {
        "text": "other ddrug0 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of ddrug1 and other ddrug2 { e , g , , ddrug3 } .",
        "triple_list": [
            [
                "ddrug1",
                "effect",
                "ddrug3"
            ]
        ]
    }
]